,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1386077,60606,Comparative Toxicogenomics Database (CTD),Clopidogrel,D000077144,Clopidogrel,https://ctdbase.org/detail.go?type=chem&acc=D000077144,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606,Homo sapiens (human),CYP3A5 gene polymorphism affects the susceptibility to clopidogrel,,,PMID:16754899,https://www.ncbi.nlm.nih.gov/pubmed/16754899,16754899,,
1,1436781,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Adefovir dipivoxil results in increased expression of BAX mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
2,1436782,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,8412,BCAR3,https://ctdbase.org/detail.go?type=gene&acc=8412,,,8412.0,BCAR3,9606,Homo sapiens (human),Adefovir dipivoxil results in increased expression of BCAR3 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
3,1436783,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,79656,BEND5,https://ctdbase.org/detail.go?type=gene&acc=79656,,,79656.0,BEND5,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of BEND5 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
4,1436784,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,90427,BMF,https://ctdbase.org/detail.go?type=gene&acc=90427,,,90427.0,BMF,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of BMF mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
5,1436908,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,134147,CMBL,https://ctdbase.org/detail.go?type=gene&acc=134147,,,134147.0,CMBL,9606,Homo sapiens (human),Adefovir dipivoxil results in increased expression of CMBL mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
6,1436909,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,1690,COCH,https://ctdbase.org/detail.go?type=gene&acc=1690,,,1690.0,COCH,9606,Homo sapiens (human),Adefovir dipivoxil results in increased expression of COCH mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
7,1436910,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,1282,COL4A1,https://ctdbase.org/detail.go?type=gene&acc=1282,,,1282.0,COL4A1,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of COL4A1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
8,1436911,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,1491,CTH,https://ctdbase.org/detail.go?type=gene&acc=1491,,,1491.0,CTH,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of CTH mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
9,1436912,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,1075,CTSC,https://ctdbase.org/detail.go?type=gene&acc=1075,,,1075.0,CTSC,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of CTSC mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
10,1436913,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606,Homo sapiens (human),Adefovir dipivoxil results in increased expression of CYP1B1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
11,1436914,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased activity of CYP2C9 protein,,,PMID:17162464,https://www.ncbi.nlm.nih.gov/pubmed/17162464,17162464,,
12,1437151,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,23710,GABARAPL1,https://ctdbase.org/detail.go?type=gene&acc=23710,,,23710.0,GABARAPL1,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of GABARAPL1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
13,1437152,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606,Homo sapiens (human),Adefovir dipivoxil results in increased expression of GADD45A mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
14,1437153,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,57452,GALNT16,https://ctdbase.org/detail.go?type=gene&acc=57452,,,57452.0,GALNT16,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of GALNT16 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
15,1437154,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,9245,GCNT3,https://ctdbase.org/detail.go?type=gene&acc=9245,,,9245.0,GCNT3,9606,Homo sapiens (human),Adefovir dipivoxil results in increased expression of GCNT3 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
16,1437155,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,9518,GDF15,https://ctdbase.org/detail.go?type=gene&acc=9518,,,9518.0,GDF15,9606,Homo sapiens (human),Adefovir dipivoxil results in increased expression of GDF15 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
17,1437156,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,2805,GOT1,https://ctdbase.org/detail.go?type=gene&acc=2805,,,2805.0,GOT1,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of GOT1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
18,1437405,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of NQO1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
19,1437406,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,9315,NREP,https://ctdbase.org/detail.go?type=gene&acc=9315,,,9315.0,NREP,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of NREP mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
20,1437407,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,84284,NTPCR,https://ctdbase.org/detail.go?type=gene&acc=84284,,,84284.0,NTPCR,9606,Homo sapiens (human),Adefovir dipivoxil results in increased expression of NTPCR mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
21,1437408,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,5033,P4HA1,https://ctdbase.org/detail.go?type=gene&acc=5033,,,5033.0,P4HA1,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of P4HA1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
22,1437409,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,53354,PANK1,https://ctdbase.org/detail.go?type=gene&acc=53354,,,53354.0,PANK1,9606,Homo sapiens (human),Adefovir dipivoxil results in decreased expression of PANK1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
23,1437410,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,10954,PDIA5,https://ctdbase.org/detail.go?type=gene&acc=10954,,,10954.0,PDIA5,9606,Homo sapiens (human),Adefovir dipivoxil results in increased expression of PDIA5 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
24,1437411,60871,Comparative Toxicogenomics Database (CTD),Adefovir Dipivoxil,C106812,adefovir dipivoxil,https://ctdbase.org/detail.go?type=chem&acc=C106812,9124,PDLIM1,https://ctdbase.org/detail.go?type=gene&acc=9124,,,9124.0,PDLIM1,9606,Homo sapiens (human),Adefovir dipivoxil results in increased expression of PDLIM1 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
25,1438985,60961,Comparative Toxicogenomics Database (CTD),Adenosine,D000241,Adenosine,https://ctdbase.org/detail.go?type=chem&acc=D000241,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606,Homo sapiens (human),Adenosine results in increased activity of CASP9 protein|thymidine inhibits the reaction [adenosine results in increased activity of CASP9 protein],,,PMID:11570579,https://www.ncbi.nlm.nih.gov/pubmed/11570579,11570579,,
26,1438986,60961,Comparative Toxicogenomics Database (CTD),Adenosine,D000241,Adenosine,https://ctdbase.org/detail.go?type=chem&acc=D000241,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10116,Rattus norvegicus (Norway rat),Adenosine results in increased activity of CASP9 protein,,,PMID:16469385,https://www.ncbi.nlm.nih.gov/pubmed/16469385,16469385,,
27,1438987,60961,Comparative Toxicogenomics Database (CTD),Adenosine,D000241,Adenosine,https://ctdbase.org/detail.go?type=chem&acc=D000241,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),Adenosine results in increased expression of CCND1 mRNA,,,PMID:34070360,https://www.ncbi.nlm.nih.gov/pubmed/34070360,34070360,,
28,1438988,60961,Comparative Toxicogenomics Database (CTD),Adenosine,D000241,Adenosine,https://ctdbase.org/detail.go?type=chem&acc=D000241,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,9606,Homo sapiens (human),Adenosine results in increased expression of CD14 mRNA,,,PMID:21538184,https://www.ncbi.nlm.nih.gov/pubmed/21538184,21538184,,
29,1438989,60961,Comparative Toxicogenomics Database (CTD),Adenosine,D000241,Adenosine,https://ctdbase.org/detail.go?type=chem&acc=D000241,8837,CFLAR,https://ctdbase.org/detail.go?type=gene&acc=8837,,,8837.0,CFLAR,9606,Homo sapiens (human),Dipyridamole inhibits the reaction [adenosine results in decreased expression of CFLAR mRNA alternative form]|dipyridamole inhibits the reaction [adenosine results in decreased expression of CFLAR mrna]|adenosine results in decreased expression of CFLAR protein|adenosine results in decreased expression of CFLAR mRNA alternative form|adenosine results in decreased expression of CFLAR mrna|dipyridamole inhibits the reaction [adenosine results in decreased expression of CFLAR protein],,,PMID:17303086,https://www.ncbi.nlm.nih.gov/pubmed/17303086,17303086,,
30,1439931,62060,Toxin and Toxin Target Database (T3DB),Endrin ketone,T3D0063,Endrin ketone,http://www.t3db.ca/toxins/T3D0063,BE0004991,Plasma membrane calcium-transporting ATPase 3,http://www.t3db.ca/biodb/bio_entities/BE0004991,Q16720,Plasma membrane calcium-transporting ATPase 3,492.0,ATP2B3,9606,Homo sapiens (human),"Endrin inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
31,1439932,62060,Toxin and Toxin Target Database (T3DB),Endrin ketone,T3D0063,Endrin ketone,http://www.t3db.ca/toxins/T3D0063,BE0004972,Plasma membrane calcium-transporting ATPase 4,http://www.t3db.ca/biodb/bio_entities/BE0004972,P23634,Plasma membrane calcium-transporting ATPase 4,493.0,ATP2B4,9606,Homo sapiens (human),"Endrin inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
32,1439933,62060,Toxin and Toxin Target Database (T3DB),Endrin ketone,T3D0063,Endrin ketone,http://www.t3db.ca/toxins/T3D0063,BE0003888,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,http://www.t3db.ca/biodb/bio_entities/BE0003888,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 ,487.0,ATP2A1,9606,Homo sapiens (human),"Endrin inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
33,1439934,62060,Toxin and Toxin Target Database (T3DB),Endrin ketone,T3D0063,Endrin ketone,http://www.t3db.ca/toxins/T3D0063,BE0003477,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,http://www.t3db.ca/biodb/bio_entities/BE0003477,P16615,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,488.0,ATP2A2,9606,Homo sapiens (human),"Endrin inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
34,1439935,62060,Toxin and Toxin Target Database (T3DB),Endrin ketone,T3D0063,Endrin ketone,http://www.t3db.ca/toxins/T3D0063,BE0005030,Sarcoplasmic/endoplasmic reticulum calcium ATPase 3,http://www.t3db.ca/biodb/bio_entities/BE0005030,Q93084,Sarcoplasmic/endoplasmic reticulum calcium ATPase 3,489.0,ATP2A3,9606,Homo sapiens (human),"Endrin inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
35,1439936,62060,Toxin and Toxin Target Database (T3DB),Endrin ketone,T3D0063,Endrin ketone,http://www.t3db.ca/toxins/T3D0063,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000732,P05023,Sodium/potassium-transporting ATPase subunit alpha-1 ,476.0,ATP1A1,9606,Homo sapiens (human),"Endrin inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
36,1439937,62060,Toxin and Toxin Target Database (T3DB),Endrin ketone,T3D0063,Endrin ketone,http://www.t3db.ca/toxins/T3D0063,BE0005034,Sodium/potassium-transporting ATPase subunit alpha-2,http://www.t3db.ca/biodb/bio_entities/BE0005034,P50993,Sodium/potassium-transporting ATPase subunit alpha-2,477.0,ATP1A2,9606,Homo sapiens (human),"Endrin inhibits na+/k+ atpase and ca2+ and mg2+ atpase, which are essential for the transport of calcium across membranes. this results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10)",,,,,,,
37,1440528,64139,IUPHAR/BPS Guide to PHARMACOLOGY,Efavirenz,11287,efavirenz,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11287,1337,CYP3A4,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1337,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606,Homo sapiens (human),Inhibition,pIC50,4.76,PMID:11225565,https://www.ncbi.nlm.nih.gov/pubmed/11225565,11225565,,
38,1440529,64150,Drug Gene Interaction database (DGIdb),Amantadine Hydrochloride,,AMANTADINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:282415,,GRIN2C,https://www.dgidb.org/genes/hgnc:4587,,,2905.0,GRIN2C,9606,Homo sapiens (human),Inhibitor,,,,,,,
39,1437807,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,10116,Rattus norvegicus (Norway rat),Ginkgo biloba extract inhibits the reaction [doxorubicin results in increased expression of BAD protein],,,PMID:18632596,https://www.ncbi.nlm.nih.gov/pubmed/18632596,18632596,,
40,1437808,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Ginkgo biloba extract inhibits the reaction [3-nitropropionic acid results in increased expression of BAX mrna],,,PMID:21827809,https://www.ncbi.nlm.nih.gov/pubmed/21827809,21827809,,
41,1438545,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10090,Mus musculus (house mouse),Ginkgo biloba extract affects the methylation of EGFR promoter,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
42,1438546,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,1977,EIF4E,https://ctdbase.org/detail.go?type=gene&acc=1977,,,1977.0,EIF4E,10090,Mus musculus (house mouse),Ginkgo biloba extract affects the methylation of EIF4E promoter,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
43,1438547,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,60528,ELAC2,https://ctdbase.org/detail.go?type=gene&acc=60528,,,60528.0,ELAC2,10090,Mus musculus (house mouse),Ginkgo biloba extract results in increased methylation of ELAC2 promoter,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
44,1438548,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,83401,ELOVL3,https://ctdbase.org/detail.go?type=gene&acc=83401,,,83401.0,ELOVL3,10090,Mus musculus (house mouse),Ginkgo biloba extract results in decreased expression of ELOVL3 mRNA,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
45,1438549,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,11082,ESM1,https://ctdbase.org/detail.go?type=gene&acc=11082,,,11082.0,ESM1,10090,Mus musculus (house mouse),Ginkgo biloba extract results in increased expression of ESM1 mrna|ginkgo biloba extract results in decreased methylation of ESM1 promoter,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
46,1438550,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,10116,Rattus norvegicus (Norway rat),Ginkgo biloba extract inhibits the reaction [3-nitropropionic acid results in increased expression of GAPDH mrna],,,PMID:21827809,https://www.ncbi.nlm.nih.gov/pubmed/21827809,21827809,,
47,1438551,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,14468,GBP2B,https://ctdbase.org/detail.go?type=gene&acc=14468,,,14468.0,Gbp2b,10090,Mus musculus (house mouse),Ginkgo biloba extract results in decreased methylation of GBP2B promoter|ginkgo biloba extract results in increased expression of GBP2B mRNA,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
48,1438552,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606,Homo sapiens (human),[ginkgo biloba extract results in increased expression of GCLC protein] which results in increased chemical synthesis of glutathione|ginkgo biloba extract results in increased expression of GCLC mrna|ginkgo biloba extract results in increased expression of GCLC protein,,,PMID:11673643,https://www.ncbi.nlm.nih.gov/pubmed/11673643,11673643,,
49,1438553,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,2731,GLDC,https://ctdbase.org/detail.go?type=gene&acc=2731,,,2731.0,GLDC,10090,Mus musculus (house mouse),Ginkgo biloba extract results in decreased expression of GLDC mRNA,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
50,1438677,64927,Comparative Toxicogenomics Database (CTD),Chloroquine Phosphate,C063170,Ginkgo biloba extract,https://ctdbase.org/detail.go?type=chem&acc=C063170,3484,IGFBP1,https://ctdbase.org/detail.go?type=gene&acc=3484,,,3484.0,IGFBP1,10090,Mus musculus (house mouse),Ginkgo biloba extract results in increased expression of IGFBP1 mRNA,,,PMID:31278416,https://www.ncbi.nlm.nih.gov/pubmed/31278416,31278416,,
51,1440779,65016,Toxin and Toxin Target Database (T3DB),Amprenavir,T3D2863,Amprenavir,http://www.t3db.ca/toxins/T3D2863,BE0000941,Cathepsin D,http://www.t3db.ca/biodb/bio_entities/BE0000941,P07339,Cathepsin D,1509.0,CTSD,9606,Homo sapiens (human),,,,PMID:17638694,https://www.ncbi.nlm.nih.gov/pubmed/17638694,17638694,,
52,1440780,65016,Toxin and Toxin Target Database (T3DB),Amprenavir,T3D2863,Amprenavir,http://www.t3db.ca/toxins/T3D2863,BE0002362,Cytochrome P450 3A5,http://www.t3db.ca/biodb/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606,Homo sapiens (human),,,,PMID:16248836,https://www.ncbi.nlm.nih.gov/pubmed/16248836,16248836,,
53,1440781,65016,Toxin and Toxin Target Database (T3DB),Amprenavir,T3D2863,Amprenavir,http://www.t3db.ca/toxins/T3D2863,BE0001032,Multidrug resistance protein 1,http://www.t3db.ca/biodb/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606,Homo sapiens (human),,,,PMID:17664327,https://www.ncbi.nlm.nih.gov/pubmed/17664327,17664327,,
54,1440782,65016,Toxin and Toxin Target Database (T3DB),Amprenavir,T3D2863,Amprenavir,http://www.t3db.ca/toxins/T3D2863,BE0000933,Cytosolic 10-formyltetrahydrofolate dehydrogenase,http://www.t3db.ca/biodb/bio_entities/BE0000933,O75891,Cytosolic 10-formyltetrahydrofolate dehydrogenase,10840.0,ALDH1L1,9606,Homo sapiens (human),,,,,,,,
55,1440783,65016,BindingDB,Amprenavir,577,"(3S)-oxolan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577,5725,Gag-Pol polyprotein [489-892],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5725,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,,,PMID:23952265|DOI:10.1021/cb400468c,https://www.ncbi.nlm.nih.gov/pubmed/23952265|https://doi.org/10.1021/cb400468c,23952265,10.1021/cb400468c,
56,1440784,65016,BindingDB,Amprenavir,577,"(3S)-oxolan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577,5726,HIV WT-A pol protein (wild-type clade A),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5726,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,,,PMID:23952265|DOI:10.1021/cb400468c,https://www.ncbi.nlm.nih.gov/pubmed/23952265|https://doi.org/10.1021/cb400468c,23952265,10.1021/cb400468c,
57,1440785,65016,BindingDB,Amprenavir,577,"(3S)-oxolan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577,5727,"Gag-Pol polyprotein [489-892,N526H,R530K,V566I,I582L,V648I,Q690K,I723V,C750S,T788A,Q795E,T874A,V881I,P882Q]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5727,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,,,PMID:23952265|DOI:10.1021/cb400468c,https://www.ncbi.nlm.nih.gov/pubmed/23952265|https://doi.org/10.1021/cb400468c,23952265,10.1021/cb400468c,
58,1441035,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7105,TSPAN6,https://ctdbase.org/detail.go?type=gene&acc=7105,,,7105.0,TSPAN6,9606,Homo sapiens (human),Epigallocatechin gallate results in decreased expression of TSPAN6 mRNA,,,PMID:16084531,https://www.ncbi.nlm.nih.gov/pubmed/16084531,16084531,,
59,1441036,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,55720,TSR1,https://ctdbase.org/detail.go?type=gene&acc=55720,,,55720.0,TSR1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of TSR1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
60,1441037,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,90121,TSR2,https://ctdbase.org/detail.go?type=gene&acc=90121,,,90121.0,TSR2,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of TSR2 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
61,1441038,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,55622,TTC27,https://ctdbase.org/detail.go?type=gene&acc=55622,,,55622.0,TTC27,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of TTC27 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
62,1441039,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,123016,TTC8,https://ctdbase.org/detail.go?type=gene&acc=123016,,,123016.0,TTC8,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of TTC8 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
63,1441040,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7272,TTK,https://ctdbase.org/detail.go?type=gene&acc=7272,,,7272.0,TTK,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of TTK mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
64,1441041,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,25809,TTLL1,https://ctdbase.org/detail.go?type=gene&acc=25809,,,25809.0,TTLL1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of TTLL1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
65,1441662,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,139596,UPRT,https://ctdbase.org/detail.go?type=gene&acc=139596,,,139596.0,UPRT,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of UPRT mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
66,1441663,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,84300,UQCC2,https://ctdbase.org/detail.go?type=gene&acc=84300,,,84300.0,UQCC2,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of UQCC2 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
67,1441664,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7381,UQCRB,https://ctdbase.org/detail.go?type=gene&acc=7381,,,7381.0,UQCRB,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of UQCRB mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
68,1441665,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7384,UQCRC1,https://ctdbase.org/detail.go?type=gene&acc=7384,,,7384.0,UQCRC1,10090,Mus musculus (house mouse),Epigallocatechin gallate results in decreased expression of UQCRC1 mRNA,,,PMID:29175576,https://www.ncbi.nlm.nih.gov/pubmed/29175576,29175576,,
69,1441666,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7385,UQCRC2,https://ctdbase.org/detail.go?type=gene&acc=7385,,,7385.0,UQCRC2,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of UQCRC2 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of UQCRC2 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
70,1441667,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,8975,USP13,https://ctdbase.org/detail.go?type=gene&acc=8975,,,8975.0,USP13,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of USP13 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
71,1441785,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,8239,USP9X,https://ctdbase.org/detail.go?type=gene&acc=8239,,,8239.0,USP9X,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of USP9X mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
72,1441786,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,10813,UTP14A,https://ctdbase.org/detail.go?type=gene&acc=10813,,,10813.0,UTP14A,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of UTP14A mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
73,1441787,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,57050,UTP3,https://ctdbase.org/detail.go?type=gene&acc=57050,,,57050.0,UTP3,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of UTP3 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
74,1441788,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,55813,UTP6,https://ctdbase.org/detail.go?type=gene&acc=55813,,,55813.0,UTP6,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of UTP6 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
75,1441789,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7402,UTRN,https://ctdbase.org/detail.go?type=gene&acc=7402,,,7402.0,UTRN,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of UTRN mrna|epigallocatechin gallate results in increased expression of UTRN mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
76,1441790,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7405,UVRAG,https://ctdbase.org/detail.go?type=gene&acc=7405,,,7405.0,UVRAG,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of UVRAG mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
77,1431101,72344,Comparative Toxicogenomics Database (CTD),Nobiletin,C008661,nobiletin,https://ctdbase.org/detail.go?type=chem&acc=C008661,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10116,Rattus norvegicus (Norway rat),[paeonol co-treated with icariin co-treated with nobiletin co-treated with ginsenosides co-treated with astragaloside A] results in decreased expression of EGFR mrna|[paeonol co-treated with icariin co-treated with nobiletin co-treated with ginsenosides co-treated with astragaloside A] results in decreased expression of and results in decreased phosphorylation of EGFR protein,,,PMID:32344236,https://www.ncbi.nlm.nih.gov/pubmed/32344236,32344236,,
78,1438408,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1062,CENPE,https://ctdbase.org/detail.go?type=gene&acc=1062,,,1062.0,CENPE,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CENPE mRNA",,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
79,1438409,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,55166,CENPQ,https://ctdbase.org/detail.go?type=gene&acc=55166,,,55166.0,CENPQ,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CENPQ mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
80,1438410,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,9859,CEP170,https://ctdbase.org/detail.go?type=gene&acc=9859,,,9859.0,CEP170,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CEP170 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
81,1438411,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1675,CFD,https://ctdbase.org/detail.go?type=gene&acc=1675,,,1675.0,CFD,30732,Oryzias melastigma (Indian medaka),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CFD mRNA",,,PMID:36116629,https://www.ncbi.nlm.nih.gov/pubmed/36116629,36116629,,
82,1438885,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1282,COL4A1,https://ctdbase.org/detail.go?type=gene&acc=1282,,,1282.0,COL4A1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of COL4A1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
83,1440087,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,100536594,CXCL8B.1,https://ctdbase.org/detail.go?type=gene&acc=100536594,,,100536594.0,cxcl8b.1,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CXCL8B.1 mrna|curcumin inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in increased expression of CXCL8B.1 mrna]",,,PMID:37423901,https://www.ncbi.nlm.nih.gov/pubmed/37423901,37423901,,
84,1440088,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1528,CYB5A,https://ctdbase.org/detail.go?type=gene&acc=1528,,,1528.0,CYB5A,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYB5A protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
85,1440089,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,80777,CYB5B,https://ctdbase.org/detail.go?type=gene&acc=80777,,,80777.0,CYB5B,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYB5B protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
86,1440090,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,51706,CYB5R1,https://ctdbase.org/detail.go?type=gene&acc=51706,,,51706.0,CYB5R1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYB5R1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
87,1440091,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1727,CYB5R3,https://ctdbase.org/detail.go?type=gene&acc=1727,,,1727.0,CYB5R3,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYB5R3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
88,1440206,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYP11A1 mRNA",,,PMID:25723718,https://www.ncbi.nlm.nih.gov/pubmed/25723718,25723718,,
89,1440207,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10090,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CYP11A1 mRNA",,,PMID:30675821,https://www.ncbi.nlm.nih.gov/pubmed/30675821,30675821,,
90,1440208,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10090,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CYP11A1 protein",,,PMID:29575470,https://www.ncbi.nlm.nih.gov/pubmed/29575470,29575470,,
91,1440209,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CYP11A1 mrna|4,4'-hexafluorisopropylidene diphenol results in decreased expression of CYP11A1 protein",,,PMID:22504055,https://www.ncbi.nlm.nih.gov/pubmed/22504055,22504055,,
92,1440210,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYP11A1 protein",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
93,1440211,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1584,CYP11B1,https://ctdbase.org/detail.go?type=gene&acc=1584,,,1584.0,CYP11B1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CYP11B1 mRNA",,,PMID:26751127,https://www.ncbi.nlm.nih.gov/pubmed/26751127,26751127,,
94,1440212,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1585,CYP11B2,https://ctdbase.org/detail.go?type=gene&acc=1585,,,1585.0,CYP11B2,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CYP11B2 mRNA",,,PMID:26751127,https://www.ncbi.nlm.nih.gov/pubmed/26751127,26751127,,
95,1440213,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CYP17A1 mRNA",,,PMID:25723718,https://www.ncbi.nlm.nih.gov/pubmed/25723718,25723718,,
96,1440214,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CYP17A1 mRNA",,,PMID:26751127|PMID:37182577,https://www.ncbi.nlm.nih.gov/pubmed/26751127|https://www.ncbi.nlm.nih.gov/pubmed/37182577,26751127|37182577,,
97,1440215,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,10090,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CYP17A1 mRNA",,,PMID:29575470|PMID:36098747|PMID:37216864,https://www.ncbi.nlm.nih.gov/pubmed/29575470|https://www.ncbi.nlm.nih.gov/pubmed/36098747|https://www.ncbi.nlm.nih.gov/pubmed/37216864,29575470|36098747|37216864,,
98,1440336,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),"[cylindrospermopsin co-treated with 4,4'-hexafluorisopropylidene diphenol] results in increased expression of CYP1A1 mrna|4,4'-hexafluorisopropylidene diphenol results in increased expression of CYP1A1 mrna|[4,4'-hexafluorisopropylidene diphenol co-treated with cylindrospermopsin] results in decreased expression of CYP1A1 mRNA",,,PMID:32244372,https://www.ncbi.nlm.nih.gov/pubmed/32244372,32244372,,
99,1440455,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,104045292,CYP1A4,https://ctdbase.org/detail.go?type=gene&acc=104045292,,,104045292.0,,9031,Gallus gallus (chicken),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYP1A4 mRNA",,,PMID:33465250|PMID:35138540,https://www.ncbi.nlm.nih.gov/pubmed/33465250|https://www.ncbi.nlm.nih.gov/pubmed/35138540,33465250|35138540,,
100,1440456,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYP1B1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
101,1440457,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,30732,Oryzias melastigma (Indian medaka),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYP1B1 mRNA",,,PMID:36116629,https://www.ncbi.nlm.nih.gov/pubmed/36116629,36116629,,
102,1440458,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10116,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYP1B1 mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
103,1440459,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1591,CYP24A1,https://ctdbase.org/detail.go?type=gene&acc=1591,,,1591.0,CYP24A1,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYP24A1 mRNA",,,PMID:37556959,https://www.ncbi.nlm.nih.gov/pubmed/37556959,37556959,,
104,1440460,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1592,CYP26A1,https://ctdbase.org/detail.go?type=gene&acc=1592,,,1592.0,CYP26A1,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol affects the expression of CYP26A1 mRNA",,,PMID:36801538,https://www.ncbi.nlm.nih.gov/pubmed/36801538,36801538,,
105,1437987,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CD14 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
106,1437988,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,10116,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of CD14 mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
107,1437989,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,977,CD151,https://ctdbase.org/detail.go?type=gene&acc=977,,,977.0,CD151,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of CD151 mrna|perfluorooctane sulfonic acid results in increased expression of CD151 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
108,1439445,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51265,CDKL3,https://ctdbase.org/detail.go?type=gene&acc=51265,,,51265.0,CDKL3,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CDKL3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
109,1439446,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of CDKN1A protein,,,PMID:29063134|PMID:32700164,https://www.ncbi.nlm.nih.gov/pubmed/29063134|https://www.ncbi.nlm.nih.gov/pubmed/32700164,29063134|32700164,,
110,1439447,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of CDKN1A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
111,1439448,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of CDKN1A mRNA,,,PMID:26300304,https://www.ncbi.nlm.nih.gov/pubmed/26300304,26300304,,
112,1439449,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of CDKN1B protein,,,PMID:29063134|PMID:32700164,https://www.ncbi.nlm.nih.gov/pubmed/29063134|https://www.ncbi.nlm.nih.gov/pubmed/32700164,29063134|32700164,,
113,1439579,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1036,CDO1,https://ctdbase.org/detail.go?type=gene&acc=1036,,,1036.0,CDO1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CDO1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of CDO1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
114,1439580,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1036,CDO1,https://ctdbase.org/detail.go?type=gene&acc=1036,,,1036.0,CDO1,10116,Rattus norvegicus (Norway rat),Perfluorooctane sulfonic acid results in decreased expression of CDO1 mRNA,,,PMID:18692542,https://www.ncbi.nlm.nih.gov/pubmed/18692542,18692542,,
115,1439694,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CEBPA mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
116,1439799,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CEBPB mrna|[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of CEBPB mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
117,1460056,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,97423,R74862,https://ctdbase.org/detail.go?type=gene&acc=97423,,,97423.0,R74862,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of R74862 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
118,1441791,82565,Comparative Toxicogenomics Database (CTD),4-Nitrophenyl beta-D-glucopyranosiduronic acid,C002730,4-nitrophenylglucuronide,https://ctdbase.org/detail.go?type=chem&acc=C002730,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,9606,Homo sapiens (human),4-nitrophenylglucuronide inhibits the reaction [ABCC4 protein results in increased transport of methotrexate],,,PMID:11856762,https://www.ncbi.nlm.nih.gov/pubmed/11856762,11856762,,
119,1441792,82634,BindingDB,"2-Amino-5-trifluoromethyl-1,3,4-thiadiazole",626137,EN300-31423,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626137,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),2440,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
120,1441793,83221,BindingDB,4-Iodo-2-methylaniline,626055,EN300-17571,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626055,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),2380,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
121,1441794,83489,Comparative Toxicogenomics Database (CTD),Eriocitrin,C114706,eriocitrin,https://ctdbase.org/detail.go?type=chem&acc=C114706,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Eriocitrin results in increased expression of BAX protein,,,PMID:34724282,https://www.ncbi.nlm.nih.gov/pubmed/34724282,34724282,,
122,1441911,83823,Drug Gene Interaction database (DGIdb),Orphenadrine Citrate,,ORPHENADRINE CITRATE,https://www.dgidb.org/drugs/rxcui:7716,,SCN9A,https://www.dgidb.org/genes/hgnc:10597,,,6335.0,SCN9A,9606,Homo sapiens (human),Blocker,,,,,,,
123,1441912,83823,Drug Gene Interaction database (DGIdb),Orphenadrine Citrate,,ORPHENADRINE CITRATE,https://www.dgidb.org/drugs/rxcui:7716,,SCN8A,https://www.dgidb.org/genes/hgnc:10596,,,6334.0,SCN8A,9606,Homo sapiens (human),Blocker,,,,,,,
124,1441913,83823,Drug Gene Interaction database (DGIdb),Orphenadrine Citrate,,ORPHENADRINE CITRATE,https://www.dgidb.org/drugs/rxcui:7716,,SCN1A,https://www.dgidb.org/genes/hgnc:10585,,,6323.0,SCN1A,9606,Homo sapiens (human),Blocker,,,,,,,
125,1441914,83939,Comparative Toxicogenomics Database (CTD),Acetaminophen sulfate,C045667,acetaminophen sulfate ester,https://ctdbase.org/detail.go?type=chem&acc=C045667,8473,OGT,https://ctdbase.org/detail.go?type=gene&acc=8473,,,8473.0,OGT,10090,Mus musculus (house mouse),OGT gene mutant form inhibits the reaction [acetaminophen results in increased abundance of acetaminophen sulfate ester],,,PMID:29325178,https://www.ncbi.nlm.nih.gov/pubmed/29325178,29325178,,
126,1441915,83944,Comparative Toxicogenomics Database (CTD),Acetaminophen glucuronide,C037386,acetaminophen glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C037386,8714,ABCC3,https://ctdbase.org/detail.go?type=gene&acc=8714,,,8714.0,ABCC3,9606,Homo sapiens (human),Acetaminophen glucuronide results in increased activity of ABCC3 protein,,,PMID:17569508,https://www.ncbi.nlm.nih.gov/pubmed/17569508,17569508,,
127,1441916,83944,Comparative Toxicogenomics Database (CTD),Acetaminophen glucuronide,C037386,acetaminophen glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C037386,8714,ABCC3,https://ctdbase.org/detail.go?type=gene&acc=8714,,,8714.0,ABCC3,10090,Mus musculus (house mouse),ABCC3 protein affects the export of acetaminophen glucuronide,,,PMID:16250050,https://www.ncbi.nlm.nih.gov/pubmed/16250050,16250050,,
128,1441917,83944,Comparative Toxicogenomics Database (CTD),Acetaminophen glucuronide,C037386,acetaminophen glucuronide,https://ctdbase.org/detail.go?type=chem&acc=C037386,8714,ABCC3,https://ctdbase.org/detail.go?type=gene&acc=8714,,,8714.0,ABCC3,10116,Rattus norvegicus (Norway rat),Ethinyl estradiol promotes the reaction [ABCC3 protein results in increased secretion of acetaminophen glucuronide],,,PMID:16554369,https://www.ncbi.nlm.nih.gov/pubmed/16554369,16554369,,
129,1437018,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,3196,TLX2,https://ctdbase.org/detail.go?type=gene&acc=3196,,,3196.0,TLX2,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TLX2 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
130,1437019,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,9032,TM4SF5,https://ctdbase.org/detail.go?type=gene&acc=9032,,,9032.0,TM4SF5,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of TM4SF5 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
131,1437020,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,117532,TMC2,https://ctdbase.org/detail.go?type=gene&acc=117532,,,117532.0,TMC2,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TMC2 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
132,1437021,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,79838,TMC5,https://ctdbase.org/detail.go?type=gene&acc=79838,,,79838.0,TMC5,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TMC5 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
133,1437022,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,9911,TMCC2,https://ctdbase.org/detail.go?type=gene&acc=9911,,,9911.0,TMCC2,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of TMCC2 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
134,1437023,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,50999,TMED5,https://ctdbase.org/detail.go?type=gene&acc=50999,,,50999.0,TMED5,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TMED5 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
135,1437024,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,54732,TMED9,https://ctdbase.org/detail.go?type=gene&acc=54732,,,54732.0,TMED9,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TMED9 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
136,1437025,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,10430,TMEM147,https://ctdbase.org/detail.go?type=gene&acc=10430,,,10430.0,TMEM147,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TMEM147 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
137,1437026,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,441151,TMEM151B,https://ctdbase.org/detail.go?type=gene&acc=441151,,,441151.0,TMEM151B,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TMEM151B mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
138,1437027,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,155006,TMEM213,https://ctdbase.org/detail.go?type=gene&acc=155006,,,155006.0,TMEM213,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TMEM213 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
139,1437148,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,64699,TMPRSS3,https://ctdbase.org/detail.go?type=gene&acc=64699,,,64699.0,TMPRSS3,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TMPRSS3 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
140,1437149,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,83857,TMTC1,https://ctdbase.org/detail.go?type=gene&acc=83857,,,83857.0,TMTC1,10116,Rattus norvegicus (Norway rat),Fullerene C60 affects the expression of TMTC1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
141,1437150,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Fullerene C60 promotes the reaction [ALB protein modified form results in increased expression of TNF protein],,,PMID:19376187,https://www.ncbi.nlm.nih.gov/pubmed/19376187,19376187,,
142,1437637,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,93587,TRMT10A,https://ctdbase.org/detail.go?type=gene&acc=93587,,,93587.0,TRMT10A,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of TRMT10A mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
143,1437638,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,26133,TRPC4AP,https://ctdbase.org/detail.go?type=gene&acc=26133,,,26133.0,TRPC4AP,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of TRPC4AP mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
144,1437639,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,54795,TRPM4,https://ctdbase.org/detail.go?type=gene&acc=54795,,,54795.0,TRPM4,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of TRPM4 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
145,1437640,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,1831,TSC22D3,https://ctdbase.org/detail.go?type=gene&acc=1831,,,1831.0,TSC22D3,10116,Rattus norvegicus (Norway rat),Fullerene C60 affects the expression of TSC22D3 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
146,1437641,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,10194,TSHZ1,https://ctdbase.org/detail.go?type=gene&acc=10194,,,10194.0,TSHZ1,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TSHZ1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
147,1437642,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,23554,TSPAN12,https://ctdbase.org/detail.go?type=gene&acc=23554,,,23554.0,TSPAN12,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TSPAN12 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
148,1437643,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,7106,TSPAN4,https://ctdbase.org/detail.go?type=gene&acc=7106,,,7106.0,TSPAN4,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of TSPAN4 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
149,1437644,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,9256,TSPOAP1,https://ctdbase.org/detail.go?type=gene&acc=9256,,,9256.0,TSPOAP1,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of TSPOAP1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
150,1437645,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,146057,TTBK2,https://ctdbase.org/detail.go?type=gene&acc=146057,,,146057.0,TTBK2,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of TTBK2 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
151,1530515,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,1264,CNN1,https://ctdbase.org/detail.go?type=gene&acc=1264,,,1264.0,CNN1,10116,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of CNN1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
152,1439443,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090,Mus musculus (house mouse),NFE2L2 protein affects the reaction [INS2 protein affects the abundance of angiotensin I (1-7)],,,PMID:29211853,https://www.ncbi.nlm.nih.gov/pubmed/29211853,29211853,,
153,1439444,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10090,Mus musculus (house mouse),Angiotensin I (1-7) inhibits the reaction [tobacco smoke pollution results in increased phosphorylation of NFKBIA protein],,,PMID:28960804,https://www.ncbi.nlm.nih.gov/pubmed/28960804,28960804,,
154,1439792,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,9606,Homo sapiens (human),[ACE2 protein results in increased cleavage of AGT protein] which results in increased abundance of angiotensin I (1-7),,,PMID:12623933,https://www.ncbi.nlm.nih.gov/pubmed/12623933,12623933,,
155,1439793,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10090,Mus musculus (house mouse),"S 17092-1 promotes the reaction [thiorphan inhibits the reaction [AGT protein results in increased abundance of angiotensin I (1-7)]]|N-benzyloxycarbonylprolylprolinal affects the reaction [PRCP protein affects the reaction [AGT protein results in increased abundance of angiotensin I (1-7)]]|S 17092-1 inhibits the reaction [AGT protein results in increased abundance of angiotensin I (1-7)]|2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [AGT protein results in increased abundance of angiotensin I (1-7)]|ACE2 protein affects the reaction [AGT protein results in increased abundance of angiotensin I (1-7)]|thiorphan inhibits the reaction [AGT protein results in increased abundance of angiotensin I (1-7)]|PREP protein affects the reaction [AGT protein results in increased abundance of angiotensin I (1-7)]|thiorphan promotes the reaction [S 17092-1 inhibits the reaction [AGT protein results in increased abundance of angiotensin I (1-7)]]|N-benzyloxycarbonylprolylprolinal inhibits the reaction [AGT protein results in increased abundance of angiotensin I (1-7)]|PRCP protein affects the reaction [AGT protein results in increased abundance of angiotensin I (1-7)]",,,PMID:31786979,https://www.ncbi.nlm.nih.gov/pubmed/31786979,31786979,,
156,1439794,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,10090,Mus musculus (house mouse),"7-ala-angiotensin (1-7) inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in increased expression of COL3A1 protein]]|angiotensin I (1-7) inhibits the reaction [AGT protein results in increased expression of COL3A1 protein]|2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in increased expression of COL3A1 protein]]",,,PMID:33007385,https://www.ncbi.nlm.nih.gov/pubmed/33007385,33007385,,
157,1439795,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10090,Mus musculus (house mouse),Angiotensin I (1-7) inhibits the reaction [tobacco smoke pollution results in increased expression of CXCL1 protein]|angiotensin I (1-7) inhibits the reaction [tobacco smoke pollution results in increased expression of CXCL1 mrna],,,PMID:28960804,https://www.ncbi.nlm.nih.gov/pubmed/28960804,28960804,,
158,1439796,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,10090,Mus musculus (house mouse),Angiotensin I (1-7) inhibits the reaction [rotenone results in increased expression of CYBB mrna]|angiotensin I (1-7) inhibits the reaction [rotenone results in increased expression of CYBB protein]|7-ala-angiotensin (1-7) inhibits the reaction [angiotensin I (1-7) inhibits the reaction [rotenone results in increased expression of CYBB protein]]|7-ala-angiotensin (1-7) inhibits the reaction [angiotensin I (1-7) inhibits the reaction [rotenone results in increased expression of CYBB mrna]],,,PMID:29665408,https://www.ncbi.nlm.nih.gov/pubmed/29665408,29665408,,
159,1439797,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Angiotensin I (1-7) inhibits the reaction [monocrotaline results in increased expression of IL1B mrna],,,PMID:20581171,https://www.ncbi.nlm.nih.gov/pubmed/20581171,20581171,,
160,1439798,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Angiotensin I (1-7) inhibits the reaction [monocrotaline results in increased expression of IL6 mrna],,,PMID:20581171,https://www.ncbi.nlm.nih.gov/pubmed/20581171,20581171,,
161,1437548,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6352,CCL5,https://ctdbase.org/detail.go?type=gene&acc=6352,,,6352.0,CCL5,9606,Homo sapiens (human),Methotrexate results in increased expression of CCL5 protein|sb 203580 promotes the reaction [methotrexate results in increased expression of CCL5 protein],,,PMID:19100307,https://www.ncbi.nlm.nih.gov/pubmed/19100307,19100307,,
162,1437549,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,20305,CCL6,https://ctdbase.org/detail.go?type=gene&acc=20305,,,20305.0,Ccl6,10090,Mus musculus (house mouse),Methotrexate affects the expression of CCL6 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
163,1437550,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6355,CCL8,https://ctdbase.org/detail.go?type=gene&acc=6355,,,6355.0,CCL8,9606,Homo sapiens (human),Methotrexate results in decreased expression of CCL8 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
164,1437551,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,9606,Homo sapiens (human),Methotrexate results in increased expression of CCN1 mRNA,,,PMID:19192274,https://www.ncbi.nlm.nih.gov/pubmed/19192274,19192274,,
165,1437552,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,9606,Homo sapiens (human),CCN2 mRNA results in decreased susceptibility to methotrexate,,,PMID:24154679,https://www.ncbi.nlm.nih.gov/pubmed/24154679,24154679,,
166,1437553,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,9606,Homo sapiens (human),Methotrexate results in decreased expression of CCN2 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
167,1437554,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,9606,Homo sapiens (human),Methotrexate results in increased expression of CCN2 mRNA,,,PMID:19192274,https://www.ncbi.nlm.nih.gov/pubmed/19192274,19192274,,
168,1437800,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,9606,Homo sapiens (human),[hydroxychloroquine co-treated with methotrexate co-treated with sulfasalazine] results in decreased expression of CD14 mRNA,,,PMID:28863153,https://www.ncbi.nlm.nih.gov/pubmed/28863153,28863153,,
169,1437801,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,977,CD151,https://ctdbase.org/detail.go?type=gene&acc=977,,,977.0,CD151,9606,Homo sapiens (human),CD151 protein affects the susceptibility to methotrexate,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
170,1437802,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,283316,CD163L1,https://ctdbase.org/detail.go?type=gene&acc=283316,,,283316.0,CD163L1,9606,Homo sapiens (human),Methotrexate results in decreased expression of CD163L1 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
171,1437803,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,930,CD19,https://ctdbase.org/detail.go?type=gene&acc=930,,,930.0,CD19,9606,Homo sapiens (human),[hydroxychloroquine co-treated with methotrexate co-treated with sulfasalazine] results in decreased expression of CD19 mRNA,,,PMID:28863153,https://www.ncbi.nlm.nih.gov/pubmed/28863153,28863153,,
172,1437804,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,930,CD19,https://ctdbase.org/detail.go?type=gene&acc=930,,,930.0,CD19,9606,Homo sapiens (human),Methotrexate results in decreased expression of CD19 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
173,1437805,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,909,CD1A,https://ctdbase.org/detail.go?type=gene&acc=909,,,909.0,CD1A,9606,Homo sapiens (human),Methotrexate results in decreased expression of CD1A mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
174,1437806,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,910,CD1B,https://ctdbase.org/detail.go?type=gene&acc=910,,,910.0,CD1B,9606,Homo sapiens (human),Methotrexate results in decreased expression of CD1B mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
175,1438404,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,54901,CDKAL1,https://ctdbase.org/detail.go?type=gene&acc=54901,,,54901.0,CDKAL1,10090,Mus musculus (house mouse),Methotrexate affects the expression of CDKAL1 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
176,1438405,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,8999,CDKL2,https://ctdbase.org/detail.go?type=gene&acc=8999,,,8999.0,CDKL2,10090,Mus musculus (house mouse),Methotrexate affects the expression of CDKL2 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
177,1438406,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),MAPK8 gene mutant form inhibits the reaction [methotrexate results in increased expression of CDKN1A protein]|acetylcysteine inhibits the reaction [methotrexate results in increased expression of CDKN1A mrna]|folic acid inhibits the reaction [methotrexate results in increased expression of CDKN1A mrna]|sapropterin inhibits the reaction [methotrexate results in increased expression of CDKN1A protein],,,PMID:22183962,https://www.ncbi.nlm.nih.gov/pubmed/22183962,22183962,,
178,1438407,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),[methotrexate co-treated with CDKN1A protein] results in decreased expression of CASP6 mrna|[methotrexate co-treated with CDKN1A protein] results in decreased expression of DFFB mrna|[methotrexate co-treated with CDKN1A protein] results in increased cleavage of CASP7 protein|[methotrexate co-treated with CDKN1A protein] results in increased expression of GADD45A mrna|[methotrexate co-treated with CDKN1A protein] results in increased expression of TNFRSF9 mrna|[methotrexate co-treated with CDKN1A protein] results in decreased expression of MYD88 mrna|[methotrexate co-treated with CDKN1A protein] results in decreased expression of BIK mrna|[methotrexate co-treated with CDKN1A protein] results in increased expression of CASP7 mrna|[methotrexate co-treated with CDKN1A protein] results in decreased expression of BNIP3 mRNA,,,PMID:18483502,https://www.ncbi.nlm.nih.gov/pubmed/18483502,18483502,,
179,1438770,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,9857,CEP350,https://ctdbase.org/detail.go?type=gene&acc=9857,,,9857.0,CEP350,9606,Homo sapiens (human),Methotrexate results in increased expression of CEP350 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
180,1438771,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,95681,CEP41,https://ctdbase.org/detail.go?type=gene&acc=95681,,,95681.0,CEP41,10090,Mus musculus (house mouse),Methotrexate affects the expression of CEP41 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
181,1438772,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,9702,CEP57,https://ctdbase.org/detail.go?type=gene&acc=9702,,,9702.0,CEP57,9606,Homo sapiens (human),CEP57 protein affects the susceptibility to methotrexate,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
182,1438773,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,91012,CERS5,https://ctdbase.org/detail.go?type=gene&acc=91012,,,91012.0,CERS5,9606,Homo sapiens (human),Methotrexate results in increased expression of CERS5 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
183,1438774,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,91012,CERS5,https://ctdbase.org/detail.go?type=gene&acc=91012,,,91012.0,CERS5,10090,Mus musculus (house mouse),Methotrexate affects the expression of CERS5 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
184,1438775,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,8824,CES2,https://ctdbase.org/detail.go?type=gene&acc=8824,,,8824.0,CES2,9606,Homo sapiens (human),Methotrexate results in decreased expression of CES2 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
185,1438776,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,23491,CES3,https://ctdbase.org/detail.go?type=gene&acc=23491,,,23491.0,CES3,10116,Rattus norvegicus (Norway rat),Methotrexate results in decreased expression of CES3 mRNA,,,PMID:15120968,https://www.ncbi.nlm.nih.gov/pubmed/15120968,15120968,,
186,1439150,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,128602,CIMIP1,https://ctdbase.org/detail.go?type=gene&acc=128602,,,128602.0,CIMIP1,9606,Homo sapiens (human),Methotrexate results in increased expression of CIMIP1 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
187,1439151,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1154,CISH,https://ctdbase.org/detail.go?type=gene&acc=1154,,,1154.0,CISH,9606,Homo sapiens (human),Methotrexate results in decreased expression of CISH mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
188,1439152,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,11113,CIT,https://ctdbase.org/detail.go?type=gene&acc=11113,,,11113.0,CIT,9606,Homo sapiens (human),Methotrexate results in decreased expression of CIT mrna|[folic acid deficiency co-treated with methotrexate] results in decreased expression of CIT mRNA,,,PMID:24657277,https://www.ncbi.nlm.nih.gov/pubmed/24657277,24657277,,
189,1439153,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,11113,CIT,https://ctdbase.org/detail.go?type=gene&acc=11113,,,11113.0,CIT,9606,Homo sapiens (human),Methotrexate results in increased expression of CIT protein,,,PMID:24736981,https://www.ncbi.nlm.nih.gov/pubmed/24736981,24736981,,
190,1440337,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,23283,CSTF2T,https://ctdbase.org/detail.go?type=gene&acc=23283,,,23283.0,CSTF2T,10090,Mus musculus (house mouse),Methotrexate affects the expression of CSTF2T mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
191,1440338,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1491,CTH,https://ctdbase.org/detail.go?type=gene&acc=1491,,,1491.0,CTH,9606,Homo sapiens (human),CTH protein affects the susceptibility to methotrexate,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
192,1440339,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1493,CTLA4,https://ctdbase.org/detail.go?type=gene&acc=1493,,,1493.0,CTLA4,9606,Homo sapiens (human),[hydroxychloroquine co-treated with methotrexate co-treated with sulfasalazine] results in decreased expression of CTLA4 mRNA,,,PMID:28863153,https://www.ncbi.nlm.nih.gov/pubmed/28863153,28863153,,
193,1440340,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1495,CTNNA1,https://ctdbase.org/detail.go?type=gene&acc=1495,,,1495.0,CTNNA1,9606,Homo sapiens (human),Methotrexate results in decreased expression of CTNNA1 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
194,1440341,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1495,CTNNA1,https://ctdbase.org/detail.go?type=gene&acc=1495,,,1495.0,CTNNA1,9606,Homo sapiens (human),Methotrexate results in increased expression of CTNNA1 mRNA,,,PMID:21678067,https://www.ncbi.nlm.nih.gov/pubmed/21678067,21678067,,
195,1440342,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606,Homo sapiens (human),Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in decreased phosphorylation of CTNNB1 protein],,,PMID:19727391,https://www.ncbi.nlm.nih.gov/pubmed/19727391,19727391,,
196,1440343,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,10116,Rattus norvegicus (Norway rat),[methotrexate co-treated with leucovorin] results in increased expression of CTNNB1 protein|methotrexate results in decreased expression of CTNNB1 protein,,,PMID:25187349,https://www.ncbi.nlm.nih.gov/pubmed/25187349,25187349,,
197,1440344,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1500,CTNND1,https://ctdbase.org/detail.go?type=gene&acc=1500,,,1500.0,CTNND1,9606,Homo sapiens (human),Methotrexate results in decreased expression of CTNND1 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
198,1440345,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1500,CTNND1,https://ctdbase.org/detail.go?type=gene&acc=1500,,,1500.0,CTNND1,9606,Homo sapiens (human),Methotrexate results in increased expression of CTNND1 mRNA,,,PMID:21678067,https://www.ncbi.nlm.nih.gov/pubmed/21678067,21678067,,
199,1440461,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1511,CTSG,https://ctdbase.org/detail.go?type=gene&acc=1511,,,1511.0,CTSG,9606,Homo sapiens (human),Methotrexate results in increased expression of CTSG mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
200,1440462,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1514,CTSL,https://ctdbase.org/detail.go?type=gene&acc=1514,,,1514.0,CTSL,10116,Rattus norvegicus (Norway rat),Methotrexate results in increased expression of CTSL mRNA,,,PMID:16005536,https://www.ncbi.nlm.nih.gov/pubmed/16005536,16005536,,
201,1440463,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1520,CTSS,https://ctdbase.org/detail.go?type=gene&acc=1520,,,1520.0,CTSS,9606,Homo sapiens (human),Methotrexate results in decreased expression of CTSS mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
202,1438161,136621,Comparative Toxicogenomics Database (CTD),Salicylideneaniline,C510217,salicylideneaniline,https://ctdbase.org/detail.go?type=chem&acc=C510217,5777,PTPN6,https://ctdbase.org/detail.go?type=gene&acc=5777,,,5777.0,PTPN6,9606,Homo sapiens (human),[oxovanadium IV binds to salicylideneaniline analog] which results in decreased activity of PTPN6 protein,,,PMID:22864521,https://www.ncbi.nlm.nih.gov/pubmed/22864521,22864521,,
203,1438162,136621,Comparative Toxicogenomics Database (CTD),Salicylideneaniline,C510217,salicylideneaniline,https://ctdbase.org/detail.go?type=chem&acc=C510217,5780,PTPN9,https://ctdbase.org/detail.go?type=gene&acc=5780,,,5780.0,PTPN9,9606,Homo sapiens (human),[oxovanadium IV binds to salicylideneaniline analog] which results in decreased activity of PTPN9 protein,,,PMID:22864521,https://www.ncbi.nlm.nih.gov/pubmed/22864521,22864521,,
204,1441918,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,26,AOC1,https://ctdbase.org/detail.go?type=gene&acc=26,,,26.0,AOC1,9031,Gallus gallus (chicken),Flame retardants results in decreased expression of AOC1 mrna|flame retardants results in increased expression of AOC1 mRNA,,,PMID:30133003,https://www.ncbi.nlm.nih.gov/pubmed/30133003,30133003,,
205,1441919,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,9606,Homo sapiens (human),[plasticizers co-treated with cosmetics co-treated with flame retardants co-treated with perfluorooctanoic acid co-treated with phytoestrogens] results in increased expression of AOX1 mRNA,,,PMID:33325755,https://www.ncbi.nlm.nih.gov/pubmed/33325755,33325755,,
206,1441920,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,7955,Danio rerio (zebrafish),Flame retardants results in increased expression of APAF1 mRNA,,,PMID:19356805,https://www.ncbi.nlm.nih.gov/pubmed/19356805,19356805,,
207,1441921,136917,Comparative Toxicogenomics Database (CTD),Hexaphenoxycyclotriphosphazene,D005411,Flame Retardants,https://ctdbase.org/detail.go?type=chem&acc=D005411,328,APEX1,https://ctdbase.org/detail.go?type=gene&acc=328,,,328.0,APEX1,9031,Gallus gallus (chicken),Flame retardants results in decreased expression of APEX1 mRNA,,,PMID:30133003,https://www.ncbi.nlm.nih.gov/pubmed/30133003,30133003,,
208,1438163,139577,Comparative Toxicogenomics Database (CTD),Ethyl 2-(4-chlorophenyl)-5-(2-furyl)oxazole-4-acetate,C052488,ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxzoleacetate,https://ctdbase.org/detail.go?type=chem&acc=C052488,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,9606,Homo sapiens (human),UGT1A1 protein results in increased glucuronidation of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxzoleacetate,,,PMID:15988124,https://www.ncbi.nlm.nih.gov/pubmed/15988124,15988124,,
209,1438886,145434,Toxin and Toxin Target Database (T3DB),Trifluoromethylisocyanide,T3D1654,Trifluoromethyl isocyanide,http://www.t3db.ca/toxins/T3D1654,BE0003987,Cytochrome c oxidase subunit 3,http://www.t3db.ca/biodb/bio_entities/BE0003987,P00414,Cytochrome c oxidase subunit 3,4514.0,COX3,9606,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
210,1438887,145659,Drug Gene Interaction database (DGIdb),Sinensetin,,SINENSETIN,https://www.dgidb.org/drugs/chembl:CHEMBL226507,,MEN1,https://www.dgidb.org/genes/hgnc:7010,,,4221.0,MEN1,9606,Homo sapiens (human),,,,,,,,
211,1438888,145726,Comparative Toxicogenomics Database (CTD),"3',4'-Dihydroxyflavone",C028288,"3',4'-dihydroxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C028288,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),"3',4'-dihydroxyflavone results in decreased activity of ABCC1 protein",,,PMID:15670588,https://www.ncbi.nlm.nih.gov/pubmed/15670588,15670588,,
212,1438889,145726,Comparative Toxicogenomics Database (CTD),"3',4'-Dihydroxyflavone",C028288,"3',4'-dihydroxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C028288,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),"3',4'-dihydroxyflavone analog inhibits the reaction [kaempferol results in increased cleavage of CASP3 protein]|3',4'-dihydroxyflavone analog inhibits the reaction [etoposide results in increased cleavage of CASP3 protein]",,,PMID:16014620,https://www.ncbi.nlm.nih.gov/pubmed/16014620,16014620,,
213,1438890,145726,Comparative Toxicogenomics Database (CTD),"3',4'-Dihydroxyflavone",C028288,"3',4'-dihydroxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C028288,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606,Homo sapiens (human),"3',4'-dihydroxyflavone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]",,,PMID:24134915,https://www.ncbi.nlm.nih.gov/pubmed/24134915,24134915,,
214,1438891,145726,Comparative Toxicogenomics Database (CTD),"3',4'-Dihydroxyflavone",C028288,"3',4'-dihydroxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C028288,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606,Homo sapiens (human),"3',4'-dihydroxyflavone results in increased expression of FN1 protein",,,PMID:26408079,https://www.ncbi.nlm.nih.gov/pubmed/26408079,26408079,,
215,1438892,145726,Comparative Toxicogenomics Database (CTD),"3',4'-Dihydroxyflavone",C028288,"3',4'-dihydroxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C028288,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),"3',4'-dihydroxyflavone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]|3',4'-dihydroxyflavone inhibits the reaction [IL1B protein results in increased secretion of IL6 protein]",,,PMID:24134915,https://www.ncbi.nlm.nih.gov/pubmed/24134915,24134915,,
216,1438893,145726,Comparative Toxicogenomics Database (CTD),"3',4'-Dihydroxyflavone",C028288,"3',4'-dihydroxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C028288,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),"3',4'-dihydroxyflavone inhibits the reaction [IL1B protein results in increased secretion of IL6 protein]",,,PMID:24134915,https://www.ncbi.nlm.nih.gov/pubmed/24134915,24134915,,
217,1438894,145726,Comparative Toxicogenomics Database (CTD),"3',4'-Dihydroxyflavone",C028288,"3',4'-dihydroxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C028288,3913,LAMB2,https://ctdbase.org/detail.go?type=gene&acc=3913,,,3913.0,LAMB2,9606,Homo sapiens (human),"3',4'-dihydroxyflavone results in increased expression of LAMB2 protein",,,PMID:26408079,https://www.ncbi.nlm.nih.gov/pubmed/26408079,26408079,,
218,1438895,145726,Comparative Toxicogenomics Database (CTD),"3',4'-Dihydroxyflavone",C028288,"3',4'-dihydroxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C028288,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606,Homo sapiens (human),"3',4'-dihydroxyflavone analog inhibits the reaction [etoposide results in increased phosphorylation of MAPK1 protein]|3',4'-dihydroxyflavone analog inhibits the reaction [kaempferol results in increased phosphorylation of MAPK1 protein]",,,PMID:16014620,https://www.ncbi.nlm.nih.gov/pubmed/16014620,16014620,,
219,1440081,154072,BindingDB,"4-Thiazolidinecarboxamide, N-(1,1-dimethylethyl)-3-((2S,3S)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-1-oxo-4-phenylbutyl)-5,5-dimethyl-,(4R)-",714,"(4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=714,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,Ki (nM),5.14,PMID:10346931|DOI:10.1021/jm980637h,https://www.ncbi.nlm.nih.gov/pubmed/10346931|https://doi.org/10.1021/jm980637h,10346931,10.1021/jm980637h,
220,1440082,154257,Drug Gene Interaction database (DGIdb),Bazedoxifene,,BAZEDOXIFENE,https://www.dgidb.org/drugs/rxcui:1441386,,ESR1,https://www.dgidb.org/genes/hgnc:3467,,,2099.0,ESR1,9606,Homo sapiens (human),,,,,,,,
221,1440083,154417,Drug Gene Interaction database (DGIdb),Hyoscyamine,,ENDO-ATROPINE,https://www.dgidb.org/drugs/chembl:CHEMBL2449003,,CYP2C9,https://www.dgidb.org/genes/hgnc:2623,,,1559.0,CYP2C9,9606,Homo sapiens (human),,,,,,,,
222,1440084,154494,Drug Gene Interaction database (DGIdb),Idazoxan hydrochloride,,IDAZOXAN HYDROCHLORIDE,https://www.dgidb.org/drugs/chembl:CHEMBL543467,,ADRA2C,https://www.dgidb.org/genes/hgnc:283,,,152.0,ADRA2C,9606,Homo sapiens (human),,,,,,,,
223,1440085,154575,DrugBank,Piclamilast,DB01791,Piclamilast,https://www.drugbank.ca/drugs/DB01791,BE0001133,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",https://www.drugbank.ca/bio_entities/BE0001133,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606,Homo sapiens (human),,,,PMID:15765929,https://www.ncbi.nlm.nih.gov/pubmed/15765929,15765929,,
224,1440086,154575,DrugBank,Piclamilast,DB01791,Piclamilast,https://www.drugbank.ca/drugs/DB01791,BE0000487,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",https://www.drugbank.ca/bio_entities/BE0000487,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",5142.0,PDE4B,9606,Homo sapiens (human),,,,PMID:15765929|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/15765929|https://www.ncbi.nlm.nih.gov/pubmed/10592235,15765929|10592235,,
225,1441042,159769,Toxin and Toxin Target Database (T3DB),Cadmium lactate,T3D0377,Cadmium lactate,http://www.t3db.ca/toxins/T3D0377,BE0003772,Mitogen-activated protein kinase 9,http://www.t3db.ca/biodb/bio_entities/BE0003772,P45984,Mitogen-activated protein kinase 9,5601.0,MAPK9,9606,Homo sapiens (human),Cadmium causes cell apoptosis by activating mitogen-activated protein kinases. (A28),,,PMID:18021293,https://www.ncbi.nlm.nih.gov/pubmed/18021293,18021293,,
226,1441043,159866,Therapeutic Target Database (TTD),"3,6,9,12,15-Pentaoxatricosan-1-ol",D08LMT,"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",https://idrblab.net/ttd/data/drug/details/D08LMT,T01318,Plasmodium Dihydroorotate dehydrogenase (Malaria DHOdehase),https://idrblab.net/ttd/data/target/details/T01318,Q08210,"Dihydroorotate dehydrogenase (quinone), mitochondrial",3885966.0,PF3D7_0603300,36329,Plasmodium falciparum 3D7,Inhibitor,,,,,,,
227,1441044,159961,Therapeutic Target Database (TTD),Eritadenine,D0G3CQ,D-Eritadenine,https://idrblab.net/ttd/data/drug/details/D0G3CQ,T68698,Adenosylhomocysteinase (AHCY),https://idrblab.net/ttd/data/target/details/T68698,P23526,Adenosylhomocysteinase,191.0,AHCY,9606,Homo sapiens (human),Inhibitor,,,,,,,
228,1473657,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,363,AQP6,https://ctdbase.org/detail.go?type=gene&acc=363,,,363.0,AQP6,9606,Homo sapiens (human),Abrine results in decreased expression of AQP6 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
229,1442052,161915,Toxin and Toxin Target Database (T3DB),Tosylmethyl isocyanide,T3D1653,Toluenesulfonylmethyl isocyanide,http://www.t3db.ca/toxins/T3D1653,BE0000648,"Glutathione reductase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000648,P00390,"Glutathione reductase, mitochondrial",2936.0,GSR,9606,Homo sapiens (human),Cyanide inhibits glutathione reductase. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
230,1442053,161915,Toxin and Toxin Target Database (T3DB),Tosylmethyl isocyanide,T3D1653,Toluenesulfonylmethyl isocyanide,http://www.t3db.ca/toxins/T3D1653,BE0001135,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0001135,P36969,Phospholipid hydroperoxide glutathione peroxidase,2879.0,GPX4,9606,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
231,1442054,161915,Toxin and Toxin Target Database (T3DB),Tosylmethyl isocyanide,T3D1653,Toluenesulfonylmethyl isocyanide,http://www.t3db.ca/toxins/T3D1653,BE0002288,Probable glutathione peroxidase 8,http://www.t3db.ca/biodb/bio_entities/BE0002288,Q8TED1,Probable glutathione peroxidase 8,493869.0,GPX8,9606,Homo sapiens (human),Cyanide inhibits glutathione peroxidases. (A75),,,PMID:7437059,https://www.ncbi.nlm.nih.gov/pubmed/7437059,7437059,,
232,1442055,161915,Toxin and Toxin Target Database (T3DB),Tosylmethyl isocyanide,T3D1653,Toluenesulfonylmethyl isocyanide,http://www.t3db.ca/toxins/T3D1653,BE0005082,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005082,O60397,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",,,9606,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
233,1442056,161915,Toxin and Toxin Target Database (T3DB),Tosylmethyl isocyanide,T3D1653,Toluenesulfonylmethyl isocyanide,http://www.t3db.ca/toxins/T3D1653,BE0002252,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002252,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",6392.0,SDHD,9606,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
234,1442057,161915,Toxin and Toxin Target Database (T3DB),Tosylmethyl isocyanide,T3D1653,Toluenesulfonylmethyl isocyanide,http://www.t3db.ca/toxins/T3D1653,BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000176,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",6389.0,SDHA,9606,Homo sapiens (human),Cyanide inhibits succinate dehydrogenases. (A76),,,PMID:2734799,https://www.ncbi.nlm.nih.gov/pubmed/2734799,2734799,,
235,1463550,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,55788,LMBRD1,https://ctdbase.org/detail.go?type=gene&acc=55788,,,55788.0,LMBRD1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LMBRD1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
236,1463551,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,64788,LMF1,https://ctdbase.org/detail.go?type=gene&acc=64788,,,64788.0,LMF1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LMF1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
237,1437980,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3579,CXCR2,https://ctdbase.org/detail.go?type=gene&acc=3579,,,3579.0,CXCR2,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of CXCR2 mRNA,,,PMID:18316174|PMID:21632981|PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/18316174|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22100608,18316174|21632981|22100608,,
238,1437981,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3579,CXCR2,https://ctdbase.org/detail.go?type=gene&acc=3579,,,3579.0,CXCR2,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CXCR2 3' UTR,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
239,1437982,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2833,CXCR3,https://ctdbase.org/detail.go?type=gene&acc=2833,,,2833.0,CXCR3,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CXCR3 mRNA,,,PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/25378103,25378103,,
240,1437983,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7852,CXCR4,https://ctdbase.org/detail.go?type=gene&acc=7852,,,7852.0,CXCR4,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CXCR4 mrna|aflatoxin B1 results in increased methylation of CXCR4 gene|decitabine inhibits the reaction [aflatoxin B1 results in decreased expression of CXCR4 mrna],,,PMID:28458013,https://www.ncbi.nlm.nih.gov/pubmed/28458013,28458013,,
241,1437984,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7852,CXCR4,https://ctdbase.org/detail.go?type=gene&acc=7852,,,7852.0,CXCR4,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of CXCR4 mRNA,,,PMID:28943387,https://www.ncbi.nlm.nih.gov/pubmed/28943387,28943387,,
242,1437985,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7852,CXCR4,https://ctdbase.org/detail.go?type=gene&acc=7852,,,7852.0,CXCR4,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CXCR4 mRNA,,,PMID:28789997,https://www.ncbi.nlm.nih.gov/pubmed/28789997,28789997,,
243,1437986,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7852,CXCR4,https://ctdbase.org/detail.go?type=gene&acc=7852,,,7852.0,CXCR4,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CXCR4 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
244,1439302,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1549,CYP2A7,https://ctdbase.org/detail.go?type=gene&acc=1549,,,1549.0,CYP2A7,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CYP2A7 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
245,1439303,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1550,CYP2A7P1,https://ctdbase.org/detail.go?type=gene&acc=1550,,,1550.0,CYP2A7P1,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of CYP2A7P1 mrna|aflatoxin B1 results in decreased expression of CYP2A7P1 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
246,1439304,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,108351992,CYP2AC1,https://ctdbase.org/detail.go?type=gene&acc=108351992,,,108351992.0,Cyp2ac1,9031,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in decreased expression of CYP2AC1 protein|aflatoxin B1 results in decreased expression of CYP2AC1 protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
247,1439305,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300.0,Cyp2b1,10116,Rattus norvegicus (Norway rat),CYP2B1 protein affects the metabolism of and results in increased activity of aflatoxin B1,,,PMID:10357798,https://www.ncbi.nlm.nih.gov/pubmed/10357798,10357798,,
248,1439306,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300.0,Cyp2b1,10116,Rattus norvegicus (Norway rat),CYP2B1 protein results in increased susceptibility to aflatoxin B1,,,PMID:2125692,https://www.ncbi.nlm.nih.gov/pubmed/2125692,2125692,,
249,1439307,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300.0,Cyp2b1,10116,Rattus norvegicus (Norway rat),CYP2B1 protein affects the metabolism of aflatoxin B1,,,PMID:15936245,https://www.ncbi.nlm.nih.gov/pubmed/15936245,15936245,,
250,1439790,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1573,CYP2J2,https://ctdbase.org/detail.go?type=gene&acc=1573,,,1573.0,CYP2J2,9606,Homo sapiens (human),CYP2J2 mRNA results in increased susceptibility to aflatoxin B1,,,PMID:29555536,https://www.ncbi.nlm.nih.gov/pubmed/29555536,29555536,,
251,1439791,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,65210,CYP2J4,https://ctdbase.org/detail.go?type=gene&acc=65210,,,65210.0,Cyp2j4,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of CYP2J4 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
252,1447115,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23390,ZDHHC17,https://ctdbase.org/detail.go?type=gene&acc=23390,,,23390.0,ZDHHC17,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZDHHC17 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
253,1447116,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84243,ZDHHC18,https://ctdbase.org/detail.go?type=gene&acc=84243,,,84243.0,ZDHHC18,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZDHHC18 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
254,1447117,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84243,ZDHHC18,https://ctdbase.org/detail.go?type=gene&acc=84243,,,84243.0,ZDHHC18,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of ZDHHC18 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
255,1438678,200103,ChEMBL,Sertaconazole Nitrate,CHEMBL1200725,SERTACONAZOLE NITRATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200725/,CHEMBL1780,Cytochrome P450 51,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1780/,P10613,Lanosterol 14-alpha demethylase,3641571.0,ERG11,237561,Candida albicans SC5314,Cytochrome P450 51 inhibitor,,,,,,,
256,1438679,202225,DrugBank,Troleandomycin,DB13179,Troleandomycin,https://www.drugbank.ca/drugs/DB13179,BE0003675,50S ribosomal protein L32,https://www.drugbank.ca/bio_entities/BE0003675,P49228,50S ribosomal protein L32,69518616.0,,243230,Deinococcus radiodurans R1,Inhibitor,,,PMID:6972981,https://www.ncbi.nlm.nih.gov/pubmed/6972981,6972981,,
257,1438680,202225,DrugBank,Troleandomycin,DB13179,Troleandomycin,https://www.drugbank.ca/drugs/DB13179,BE0003674,50S ribosomal protein L4,https://www.drugbank.ca/bio_entities/BE0003674,P60723,50S ribosomal protein L4,84234838.0,,83333,Escherichia coli K-12,Inhibitor,,,PMID:6972981,https://www.ncbi.nlm.nih.gov/pubmed/6972981,6972981,,
258,1438681,202225,DrugBank,Troleandomycin,DB13179,Troleandomycin,https://www.drugbank.ca/drugs/DB13179,BE0000956,Nuclear receptor subfamily 1 group I member 2,https://www.drugbank.ca/bio_entities/BE0000956,O75469,Nuclear receptor subfamily 1 group I member 2,8856.0,NR1I2,9606,Homo sapiens (human),Activator,,,PMID:15039302,https://www.ncbi.nlm.nih.gov/pubmed/15039302,15039302,,
259,1438682,202225,DrugBank,Troleandomycin,DB13179,Troleandomycin,https://www.drugbank.ca/drugs/DB13179,BE0003550,Cytochrome P450 3A43,https://www.drugbank.ca/bio_entities/BE0003550,Q9HB55,Cytochrome P450 3A43 ,64816.0,CYP3A43,9606,Homo sapiens (human),Inducer,,,PMID:11095572,https://www.ncbi.nlm.nih.gov/pubmed/11095572,11095572,,
260,1438683,202225,DrugBank,Troleandomycin,DB13179,Troleandomycin,https://www.drugbank.ca/drugs/DB13179,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606,Homo sapiens (human),Inhibitor,,,PMID:26721703,https://www.ncbi.nlm.nih.gov/pubmed/26721703,26721703,,
261,1438684,202225,DrugBank,Troleandomycin,DB13179,Troleandomycin,https://www.drugbank.ca/drugs/DB13179,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606,Homo sapiens (human),Substrate|Inhibitor,,,,,,,
262,1438685,202225,DrugBank,Troleandomycin,DB13179,Troleandomycin,https://www.drugbank.ca/drugs/DB13179,BE0003612,Cytochrome P450 3A7,https://www.drugbank.ca/bio_entities/BE0003612,P24462,Cytochrome P450 3A7,100861540.0,CYP3A7-CYP3A51P,9606,Homo sapiens (human),Inhibitor,,,,,,,
263,1438686,202225,DrugBank,Troleandomycin,DB13179,Troleandomycin,https://www.drugbank.ca/drugs/DB13179,BE0002362,Cytochrome P450 3A5,https://www.drugbank.ca/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606,Homo sapiens (human),Inhibitor,,,PMID:15557344,https://www.ncbi.nlm.nih.gov/pubmed/15557344,15557344,,
264,1440618,207112,BindingDB,Ethyl 2-(piperazin-1-yl)acetate,36370,CID207112,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=36370,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606,Homo sapiens (human),,,,PMID:16936720|DOI:10.1038/nchembio814,https://www.ncbi.nlm.nih.gov/pubmed/16936720|https://doi.org/10.1038/nchembio814,16936720,10.1038/nchembio814,
265,1440619,207838,Drug Gene Interaction database (DGIdb),(R)-Procyclidine,,(R)-PROCYCLIDINE,https://www.dgidb.org/drugs/chembl:CHEMBL400598,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606,Homo sapiens (human),,,,,,,,
266,1440620,208820,Drug Gene Interaction database (DGIdb),Dexefaroxan,,DEXEFAROXAN,https://www.dgidb.org/drugs/ncit:C77943,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606,Homo sapiens (human),,,,,,,,
267,1440621,208901,Drug Gene Interaction database (DGIdb),Tesaglitazar,,TESAGLITAZAR,https://www.dgidb.org/drugs/ncit:C75985,,PPARG,https://www.dgidb.org/genes/hgnc:9236,,,5468.0,PPARG,9606,Homo sapiens (human),Agonist,,,,,,,
268,1440622,208908,Drug Gene Interaction database (DGIdb),Lapatinib,,LAPATINIB,https://www.dgidb.org/drugs/rxcui:480167,,ERBB2,https://www.dgidb.org/genes/hgnc:3430,,,2064.0,ERBB2,9606,Homo sapiens (human),,,,,,,,
269,1439298,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0004990,"Cytochrome c oxidase subunit 7B2, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0004990,Q8TF08,"Cytochrome c oxidase subunit 7B2, mitochondrial",170712.0,COX7B2,9606,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
270,1439299,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0003992,"Cytochrome c oxidase subunit 7C, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003992,P15954,"Cytochrome c oxidase subunit 7C, mitochondrial",1350.0,COX7C,9606,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
271,1439300,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0003993,"Cytochrome c oxidase subunit 8A, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003993,P10176,"Cytochrome c oxidase subunit 8A, mitochondrial",1351.0,COX8A,9606,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
272,1439301,220601,Toxin and Toxin Target Database (T3DB),Isobornyl thiocyanoacetate,T3D1677,Isobornyl thiocyanoacetate,http://www.t3db.ca/toxins/T3D1677,BE0003987,Cytochrome c oxidase subunit 3,http://www.t3db.ca/biodb/bio_entities/BE0003987,P00414,Cytochrome c oxidase subunit 3,4514.0,COX3,9606,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
273,1441254,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,10116,Rattus norvegicus (Norway rat),Fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of ABCC4 mrna]|estradiol 3-benzoate results in increased expression of ABCC4 protein|estradiol 3-benzoate results in increased expression of ABCC4 mrna|estradiol 3-benzoate results in decreased expression of ABCC4 protein,,,PMID:23707492,https://www.ncbi.nlm.nih.gov/pubmed/23707492,23707492,,
274,1441255,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,10057,ABCC5,https://ctdbase.org/detail.go?type=gene&acc=10057,,,10057.0,ABCC5,10116,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in increased expression of ABCC5 mrna|estradiol 3-benzoate results in increased expression of ABCC5 protein|estradiol 3-benzoate affects the expression of ABCC5 protein,,,PMID:23707492,https://www.ncbi.nlm.nih.gov/pubmed/23707492,23707492,,
275,1441256,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,10057,ABCC5,https://ctdbase.org/detail.go?type=gene&acc=10057,,,10057.0,ABCC5,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ABCC5 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
276,1441257,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,6833,ABCC8,https://ctdbase.org/detail.go?type=gene&acc=6833,,,6833.0,ABCC8,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ABCC8 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
277,1441258,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,10060,ABCC9,https://ctdbase.org/detail.go?type=gene&acc=10060,,,10060.0,ABCC9,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ABCC9 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
278,1440613,236702,DrugBank,Dexamethasone acetate,DB14649,Dexamethasone acetate,https://www.drugbank.ca/drugs/DB14649,BE0000731,"Cytochrome P450 11B1, mitochondrial",https://www.drugbank.ca/bio_entities/BE0000731,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606,Homo sapiens (human),Inhibitor,,,PMID:11600544,https://www.ncbi.nlm.nih.gov/pubmed/11600544,11600544,,
279,1440614,236702,DrugBank,Dexamethasone acetate,DB14649,Dexamethasone acetate,https://www.drugbank.ca/drugs/DB14649,BE0000131,Corticosteroid 11-beta-dehydrogenase isozyme 2,https://www.drugbank.ca/bio_entities/BE0000131,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,3291.0,HSD11B2,9606,Homo sapiens (human),Substrate,,,PMID:9141556|PMID:9618784,https://www.ncbi.nlm.nih.gov/pubmed/9141556|https://www.ncbi.nlm.nih.gov/pubmed/9618784,9141556|9618784,,
280,1440615,236702,DrugBank,Dexamethasone acetate,DB14649,Dexamethasone acetate,https://www.drugbank.ca/drugs/DB14649,BE0000329,Corticosteroid 11-beta-dehydrogenase isozyme 1,https://www.drugbank.ca/bio_entities/BE0000329,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290.0,HSD11B1,9606,Homo sapiens (human),Substrate,,,PMID:9141556|PMID:9618784,https://www.ncbi.nlm.nih.gov/pubmed/9141556|https://www.ncbi.nlm.nih.gov/pubmed/9618784,9141556|9618784,,
281,1440616,236702,DrugBank,Dexamethasone acetate,DB14649,Dexamethasone acetate,https://www.drugbank.ca/drugs/DB14649,BE0000703,Bile salt export pump,https://www.drugbank.ca/bio_entities/BE0000703,O95342,Bile salt export pump,8647.0,ABCB11,9606,Homo sapiens (human),Inducer,,,PMID:11557128,https://www.ncbi.nlm.nih.gov/pubmed/11557128,11557128,,
282,1440617,236702,DrugBank,Dexamethasone acetate,DB14649,Dexamethasone acetate,https://www.drugbank.ca/drugs/DB14649,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606,Homo sapiens (human),Substrate|Inhibitor|Inducer,,,PMID:11297522|PMID:12387747|PMID:8845310|PMID:11602674|PMID:12699389|PMID:11785684|PMID:14661924|PMID:7560060|PMID:24451000,https://www.ncbi.nlm.nih.gov/pubmed/11297522|https://www.ncbi.nlm.nih.gov/pubmed/12387747|https://www.ncbi.nlm.nih.gov/pubmed/8845310|https://www.ncbi.nlm.nih.gov/pubmed/11602674|https://www.ncbi.nlm.nih.gov/pubmed/12699389|https://www.ncbi.nlm.nih.gov/pubmed/11785684|https://www.ncbi.nlm.nih.gov/pubmed/14661924|https://www.ncbi.nlm.nih.gov/pubmed/7560060|https://www.ncbi.nlm.nih.gov/pubmed/24451000,11297522|12387747|8845310|11602674|12699389|11785684|14661924|7560060|24451000,,
283,1437636,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178,AGL,https://ctdbase.org/detail.go?type=gene&acc=178,,,178.0,AGL,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of AGL mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
284,1438544,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,36651,NAPI-T,https://ctdbase.org/detail.go?type=gene&acc=36651,,,36651.0,NaPi-T,7227,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of NAPI-T mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
285,1438777,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,89796,NAV1,https://ctdbase.org/detail.go?type=gene&acc=89796,,,89796.0,NAV1,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NAV1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
286,1438778,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,89796,NAV1,https://ctdbase.org/detail.go?type=gene&acc=89796,,,89796.0,NAV1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of NAV1 mRNA,,,PMID:23179753|PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|26272509|27188386,,
287,1439154,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55706,NDC1,https://ctdbase.org/detail.go?type=gene&acc=55706,,,55706.0,NDC1,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of NDC1 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
288,1439155,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,80762,NDFIP1,https://ctdbase.org/detail.go?type=gene&acc=80762,,,80762.0,NDFIP1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of NDFIP1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
289,1439156,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,80762,NDFIP1,https://ctdbase.org/detail.go?type=gene&acc=80762,,,80762.0,NDFIP1,10090,Mus musculus (house mouse),Methylmercuric chloride results in decreased expression of NDFIP1 mRNA,,,PMID:29261810,https://www.ncbi.nlm.nih.gov/pubmed/29261810,29261810,,
290,1439157,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,54602,NDFIP2,https://ctdbase.org/detail.go?type=gene&acc=54602,,,54602.0,NDFIP2,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NDFIP2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
291,1439158,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,100305319,NDKB,https://ctdbase.org/detail.go?type=gene&acc=100305319,,,100305319.0,,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of NDKB mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
292,1439159,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4692,NDN,https://ctdbase.org/detail.go?type=gene&acc=4692,,,4692.0,NDN,10090,Mus musculus (house mouse),Methylmercuric chloride affects the expression of NDN mRNA,,,PMID:21613230,https://www.ncbi.nlm.nih.gov/pubmed/21613230,21613230,,
293,1439160,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,27158,NDOR1,https://ctdbase.org/detail.go?type=gene&acc=27158,,,27158.0,NDOR1,7955,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of NDOR1 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
294,1439581,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55608,ANKRD10,https://ctdbase.org/detail.go?type=gene&acc=55608,,,55608.0,ANKRD10,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ANKRD10 mRNA,,,PMID:23179753|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|27188386|28001369,,
295,1439582,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,29123,ANKRD11,https://ctdbase.org/detail.go?type=gene&acc=29123,,,29123.0,ANKRD11,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ANKRD11 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
296,1439583,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,29123,ANKRD11,https://ctdbase.org/detail.go?type=gene&acc=29123,,,29123.0,ANKRD11,9606,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD11 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
297,1439584,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23253,ANKRD12,https://ctdbase.org/detail.go?type=gene&acc=23253,,,23253.0,ANKRD12,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ANKRD12 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
298,1439585,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,81573,ANKRD13C,https://ctdbase.org/detail.go?type=gene&acc=81573,,,81573.0,ANKRD13C,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ANKRD13C mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
299,1439586,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,118932,ANKRD22,https://ctdbase.org/detail.go?type=gene&acc=118932,,,118932.0,ANKRD22,7955,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of ANKRD22 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
300,1439587,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,22852,ANKRD26,https://ctdbase.org/detail.go?type=gene&acc=22852,,,22852.0,ANKRD26,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ANKRD26 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
301,1439695,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,651746,ANKRD33B,https://ctdbase.org/detail.go?type=gene&acc=651746,,,651746.0,ANKRD33B,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ANKRD33B mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
302,1439696,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,353322,ANKRD37,https://ctdbase.org/detail.go?type=gene&acc=353322,,,353322.0,ANKRD37,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ANKRD37 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
303,1439697,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,353322,ANKRD37,https://ctdbase.org/detail.go?type=gene&acc=353322,,,353322.0,ANKRD37,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of ANKRD37 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
304,1439698,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,91526,ANKRD44,https://ctdbase.org/detail.go?type=gene&acc=91526,,,91526.0,ANKRD44,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ANKRD44 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
305,1439699,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,57182,ANKRD50,https://ctdbase.org/detail.go?type=gene&acc=57182,,,57182.0,ANKRD50,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ANKRD50 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
306,1439700,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,283373,ANKRD52,https://ctdbase.org/detail.go?type=gene&acc=283373,,,283373.0,ANKRD52,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ANKRD52 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
307,1439701,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,22881,ANKRD6,https://ctdbase.org/detail.go?type=gene&acc=22881,,,22881.0,ANKRD6,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ANKRD6 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
308,1439702,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,124401,ANKS3,https://ctdbase.org/detail.go?type=gene&acc=124401,,,124401.0,ANKS3,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of ANKS3 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
309,1439929,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,306,ANXA3,https://ctdbase.org/detail.go?type=gene&acc=306,,,306.0,ANXA3,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ANXA3 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
310,1439930,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307.0,ANXA4,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ANXA4 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
311,1440520,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,350,APOH,https://ctdbase.org/detail.go?type=gene&acc=350,,,350.0,APOH,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of APOH mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
312,1440521,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,81575,APOLD1,https://ctdbase.org/detail.go?type=gene&acc=81575,,,81575.0,APOLD1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of APOLD1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
313,1440522,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55937,APOM,https://ctdbase.org/detail.go?type=gene&acc=55937,,,55937.0,APOM,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of APOM mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
314,1440523,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,139322,APOOL,https://ctdbase.org/detail.go?type=gene&acc=139322,,,139322.0,APOOL,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of APOOL mrna|methylmercuric chloride results in increased expression of APOOL mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
315,1440524,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,26060,APPL1,https://ctdbase.org/detail.go?type=gene&acc=26060,,,26060.0,APPL1,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of APPL1 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
316,1440525,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,39226,APS,https://ctdbase.org/detail.go?type=gene&acc=39226,,,39226.0,Aps,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of APS mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
317,1440526,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174376,APTF-4,https://ctdbase.org/detail.go?type=gene&acc=174376,,,174376.0,aptf-4,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of APTF-4 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
318,1440527,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174190,AQP-1,https://ctdbase.org/detail.go?type=gene&acc=174190,,,174190.0,aqp-1,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of AQP-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
319,1440890,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,89839,ARHGAP11B,https://ctdbase.org/detail.go?type=gene&acc=89839,,,89839.0,ARHGAP11B,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ARHGAP11B mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
320,1440891,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55843,ARHGAP15,https://ctdbase.org/detail.go?type=gene&acc=55843,,,55843.0,ARHGAP15,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARHGAP15 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
321,1440892,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,93663,ARHGAP18,https://ctdbase.org/detail.go?type=gene&acc=93663,,,93663.0,ARHGAP18,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARHGAP18 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
322,1440893,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,57584,ARHGAP21,https://ctdbase.org/detail.go?type=gene&acc=57584,,,57584.0,ARHGAP21,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ARHGAP21 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
323,1440894,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,101883923,ARHGAP21A,https://ctdbase.org/detail.go?type=gene&acc=101883923,,,101883923.0,arhgap21a,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of ARHGAP21A mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
324,1440895,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,57636,ARHGAP23,https://ctdbase.org/detail.go?type=gene&acc=57636,,,57636.0,ARHGAP23,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ARHGAP23 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
325,1441145,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,50649,ARHGEF4,https://ctdbase.org/detail.go?type=gene&acc=50649,,,50649.0,ARHGEF4,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARHGEF4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
326,1441146,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,7984,ARHGEF5,https://ctdbase.org/detail.go?type=gene&acc=7984,,,7984.0,ARHGEF5,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of ARHGEF5 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
327,1441147,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9459,ARHGEF6,https://ctdbase.org/detail.go?type=gene&acc=9459,,,9459.0,ARHGEF6,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARHGEF6 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
328,1441148,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8874,ARHGEF7,https://ctdbase.org/detail.go?type=gene&acc=8874,,,8874.0,ARHGEF7,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of ARHGEF7 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
329,1441149,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8874,ARHGEF7,https://ctdbase.org/detail.go?type=gene&acc=8874,,,8874.0,ARHGEF7,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARHGEF7 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
330,1441150,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23229,ARHGEF9,https://ctdbase.org/detail.go?type=gene&acc=23229,,,23229.0,ARHGEF9,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARHGEF9 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
331,1441402,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51329,ARL6IP4,https://ctdbase.org/detail.go?type=gene&acc=51329,,,51329.0,ARL6IP4,7955,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of ARL6IP4 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
332,1441403,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10550,ARL6IP5,https://ctdbase.org/detail.go?type=gene&acc=10550,,,10550.0,ARL6IP5,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARL6IP5 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
333,1441404,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55207,ARL8B,https://ctdbase.org/detail.go?type=gene&acc=55207,,,55207.0,ARL8B,9483,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride affects the expression of ARL8B protein,,,PMID:27012723,https://www.ncbi.nlm.nih.gov/pubmed/27012723,27012723,,
334,1441405,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55207,ARL8B,https://ctdbase.org/detail.go?type=gene&acc=55207,,,55207.0,ARL8B,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ARL8B mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
335,1441406,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55207,ARL8B,https://ctdbase.org/detail.go?type=gene&acc=55207,,,55207.0,ARL8B,9606,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARL8B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
336,1441407,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,25852,ARMC8,https://ctdbase.org/detail.go?type=gene&acc=25852,,,25852.0,ARMC8,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ARMC8 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
337,1441529,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,409,ARRB2,https://ctdbase.org/detail.go?type=gene&acc=409,,,409.0,ARRB2,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of ARRB2 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
338,1441530,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173454,ARRD-1,https://ctdbase.org/detail.go?type=gene&acc=173454,,,173454.0,arrd-1,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of ARRD-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
339,1436785,439763,Comparative Toxicogenomics Database (CTD),Taurolithocholic acid,D013658,Taurolithocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D013658,9294,S1PR2,https://ctdbase.org/detail.go?type=gene&acc=9294,,,9294.0,S1PR2,10116,Rattus norvegicus (Norway rat),S1PR2 protein affects the reaction [taurolithocholic acid results in decreased activity of ABCC2 protein]|s1pr2 protein affects the reaction [taurolithocholic acid results in increased phosphorylation of AKT1 protein],,,PMID:31300867,https://www.ncbi.nlm.nih.gov/pubmed/31300867,31300867,,
340,1436786,439763,Comparative Toxicogenomics Database (CTD),Taurolithocholic acid,D013658,Taurolithocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D013658,6822,SULT2A1,https://ctdbase.org/detail.go?type=gene&acc=6822,,,6822.0,SULT2A1,9606,Homo sapiens (human),SULT2A1 protein results in increased sulfation of taurolithocholic acid,,,PMID:36473578,https://www.ncbi.nlm.nih.gov/pubmed/36473578,36473578,,
341,1436787,439918,Toxin and Toxin Target Database (T3DB),Guanidinosuccinic acid,T3D4174,Guanidinosuccinic acid,http://www.t3db.ca/toxins/T3D4174,BE0005578,Klotho,http://www.t3db.ca/biodb/bio_entities/BE0005578,Q9UEF7,Klotho,9365.0,KL,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
342,1436788,439918,Toxin and Toxin Target Database (T3DB),Guanidinosuccinic acid,T3D4174,Guanidinosuccinic acid,http://www.t3db.ca/toxins/T3D4174,BE0005579,NADPH oxidase 4,http://www.t3db.ca/biodb/bio_entities/BE0005579,Q9NPH5,NADPH oxidase 4,50507.0,NOX4,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
343,1436915,439939,Toxin and Toxin Target Database (T3DB),(2S)-2-hydroxypentanedioic acid,T3D4247,L-2-Hydroxyglutaric acid,http://www.t3db.ca/toxins/T3D4247,BE0005576,Lysine-specific demethylase 4C,http://www.t3db.ca/biodb/bio_entities/BE0005576,Q9H3R0,Lysine-specific demethylase 4C,23081.0,KDM4C,9606,Homo sapiens (human),,,,PMID:21955276|PMID:21251613|PMID:21460794,https://www.ncbi.nlm.nih.gov/pubmed/21955276|https://www.ncbi.nlm.nih.gov/pubmed/21251613|https://www.ncbi.nlm.nih.gov/pubmed/21460794,21955276|21251613|21460794,,
344,1436916,439939,Toxin and Toxin Target Database (T3DB),(2S)-2-hydroxypentanedioic acid,T3D4247,L-2-Hydroxyglutaric acid,http://www.t3db.ca/toxins/T3D4247,BE0005795,Alpha-ketoglutarate-dependent dioxygenase FTO,http://www.t3db.ca/biodb/bio_entities/BE0005795,Q9C0B1,Alpha-ketoglutarate-dependent dioxygenase FTO,79068.0,FTO,9606,Homo sapiens (human),,,,PMID:23547775,https://www.ncbi.nlm.nih.gov/pubmed/23547775,23547775,,
345,1436917,439939,Toxin and Toxin Target Database (T3DB),(2S)-2-hydroxypentanedioic acid,T3D4247,L-2-Hydroxyglutaric acid,http://www.t3db.ca/toxins/T3D4247,BE0005851,Histone lysine demethylase PHF8,http://www.t3db.ca/biodb/bio_entities/BE0005851,Q9UPP1,Histone lysine demethylase PHF8,23133.0,PHF8,9606,Homo sapiens (human),,,,PMID:21251613|PMID:21460794,https://www.ncbi.nlm.nih.gov/pubmed/21251613|https://www.ncbi.nlm.nih.gov/pubmed/21460794,21251613|21460794,,
346,1437286,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,476,ATP1A1,https://ctdbase.org/detail.go?type=gene&acc=476,,,476.0,ATP1A1,9823,Sus scrofa (pig),Digitoxin results in decreased activity of ATP1A1 protein,,,PMID:28438630,https://www.ncbi.nlm.nih.gov/pubmed/28438630,28438630,,
347,1437287,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606,Homo sapiens (human),Digitoxin results in decreased expression of BIRC5 protein|digitoxin analog results in decreased expression of BIRC5 protein,,,PMID:22037315,https://www.ncbi.nlm.nih.gov/pubmed/22037315,22037315,,
348,1437288,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),HIF1A protein affects the reaction [digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP3 protein]]|digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP3 protein]|stat3 protein affects the reaction [digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP3 protein]]|digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP3 protein],,,PMID:34717917,https://www.ncbi.nlm.nih.gov/pubmed/34717917,34717917,,
349,1437289,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Digitoxin results in decreased expression of CASP3 protein|digitoxin analog results in decreased expression of CASP3 protein,,,PMID:22037315,https://www.ncbi.nlm.nih.gov/pubmed/22037315,22037315,,
350,1437290,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9823,Sus scrofa (pig),Digitoxin results in decreased cleavage of CASP3 protein,,,PMID:28438630,https://www.ncbi.nlm.nih.gov/pubmed/28438630,28438630,,
351,1437291,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606,Homo sapiens (human),HIF1A protein affects the reaction [digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP8 protein]]|digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP8 protein]|digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP8 protein]|stat3 protein affects the reaction [digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP8 protein]],,,PMID:34717917,https://www.ncbi.nlm.nih.gov/pubmed/34717917,34717917,,
352,1437292,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606,Homo sapiens (human),Digitoxin analog results in increased cleavage of CASP8 protein,,,PMID:22037315,https://www.ncbi.nlm.nih.gov/pubmed/22037315,22037315,,
353,1437293,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606,Homo sapiens (human),Digitoxin results in increased cleavage of CASP8 protein,,,PMID:22037315|PMID:34717917,https://www.ncbi.nlm.nih.gov/pubmed/22037315|https://www.ncbi.nlm.nih.gov/pubmed/34717917,22037315|34717917,,
354,1437294,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606,Homo sapiens (human),Digitoxin results in increased cleavage of CASP9 protein|digitoxin analog results in increased cleavage of CASP9 protein,,,PMID:22037315,https://www.ncbi.nlm.nih.gov/pubmed/22037315,22037315,,
355,1437295,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606,Homo sapiens (human),Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]],,,PMID:19446813,https://www.ncbi.nlm.nih.gov/pubmed/19446813,19446813,,
356,1437412,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606,Homo sapiens (human),Digitoxin inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein],,,PMID:19446813,https://www.ncbi.nlm.nih.gov/pubmed/19446813,19446813,,
357,1437413,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606,Homo sapiens (human),Digitoxin results in decreased expression of CCNB1 protein|digitoxin analog results in decreased expression of CCNB1 protein|digitoxin results in decreased expression of [CCNB1 protein binds to CDK1 protein]|digitoxin analog results in decreased expression of [CCNB1 protein binds to CDK1 protein],,,PMID:22037315,https://www.ncbi.nlm.nih.gov/pubmed/22037315,22037315,,
358,1437414,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),Digitoxin promotes the reaction [STAT3 protein affects the expression of CCND1 protein]|digitoxin promotes the reaction [HIF1A protein affects the expression of CCND1 protein]|hif1a protein affects the reaction [digitoxin promotes the reaction [STAT3 protein affects the expression of CCND1 protein]]|digitoxin results in decreased expression of CCND1 protein|stat3 protein affects the reaction [digitoxin promotes the reaction [HIF1A protein affects the expression of CCND1 protein]],,,PMID:34717917,https://www.ncbi.nlm.nih.gov/pubmed/34717917,34717917,,
359,1437545,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,55215,FANCI,https://ctdbase.org/detail.go?type=gene&acc=55215,,,55215.0,FANCI,9606,Homo sapiens (human),Digitoxin inhibits the reaction [mitomycin results in increased expression of and affects the ubiquitination of FANCI protein],,,PMID:24124520,https://www.ncbi.nlm.nih.gov/pubmed/24124520,24124520,,
360,1437546,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),STAT3 protein affects the reaction [digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP8 protein]]|digitoxin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [oxygen deficiency results in increased expression of HIF1A protein]]|hif1a protein affects the reaction [digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP8 protein]]|hif1a protein affects the reaction [digitoxin promotes the reaction [STAT3 protein affects the expression of CCND1 protein]]|hif1a protein affects the reaction [digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP3 protein]]|stat3 protein affects the reaction [digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP3 protein]]|digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP8 protein]|digitoxin promotes the reaction [HIF1A protein affects the expression of CCND1 protein]|digitoxin inhibits the reaction [oxygen deficiency results in increased expression of HIF1A protein]|digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP3 protein]|stat3 protein affects the reaction [digitoxin promotes the reaction [HIF1A protein affects the expression of CCND1 protein]],,,PMID:34717917,https://www.ncbi.nlm.nih.gov/pubmed/34717917,34717917,,
361,1437547,441207,Comparative Toxicogenomics Database (CTD),Digitoxin,D004074,Digitoxin,https://ctdbase.org/detail.go?type=chem&acc=D004074,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),Digitoxin inhibits the reaction [IL1B protein results in increased activity of MAPK3 protein]|digitoxin inhibits the reaction [IL1B protein results in increased activity of MAPK1 protein]|digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]|digitoxin inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [digitoxin inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]]|digitoxin inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein],,,PMID:19446813,https://www.ncbi.nlm.nih.gov/pubmed/19446813,19446813,,
362,1495559,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,6235,RPS29,https://ctdbase.org/detail.go?type=gene&acc=6235,,,6235.0,RPS29,10116,Rattus norvegicus (Norway rat),Propiverine binds to RPS29 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
363,1495560,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,6189,RPS3A,https://ctdbase.org/detail.go?type=gene&acc=6189,,,6189.0,RPS3A,10116,Rattus norvegicus (Norway rat),Propiverine binds to RPS3A protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
364,1495561,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,6202,RPS8,https://ctdbase.org/detail.go?type=gene&acc=6202,,,6202.0,RPS8,10116,Rattus norvegicus (Norway rat),Propiverine binds to RPS8 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
365,1438155,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Cyanidin-3-O-beta-glucopyranoside results in increased expression of BAX protein,,,PMID:34362378,https://www.ncbi.nlm.nih.gov/pubmed/34362378,34362378,,
366,1438156,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Cyanidin-3-O-beta-glucopyranoside results in decreased expression of BCL2 protein,,,PMID:34362378,https://www.ncbi.nlm.nih.gov/pubmed/34362378,34362378,,
367,1438157,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,843,CASP10,https://ctdbase.org/detail.go?type=gene&acc=843,,,843.0,CASP10,9606,Homo sapiens (human),Cyanidin-3-O-beta-glucopyranoside results in decreased expression of CASP10 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
368,1438158,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Cyanidin-3-O-beta-glucopyranoside inhibits the reaction [oxygen deficiency results in increased activity of CASP3 protein],,,PMID:24518827,https://www.ncbi.nlm.nih.gov/pubmed/24518827,24518827,,
369,1438159,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Cyanidin-3-O-beta-glucopyranoside results in increased expression of CASP3 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
370,1438160,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606,Homo sapiens (human),Cyanidin-3-O-beta-glucopyranoside results in increased expression of CASP8 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
371,1438268,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,1390,CREM,https://ctdbase.org/detail.go?type=gene&acc=1390,,,1390.0,CREM,10090,Mus musculus (house mouse),Cyanidin-3-O-beta-glucopyranoside inhibits the reaction [cadmium chloride results in decreased expression of CREM protein],,,PMID:31014900,https://www.ncbi.nlm.nih.gov/pubmed/31014900,31014900,,
372,1438269,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10090,Mus musculus (house mouse),Cyanidin-3-O-beta-glucopyranoside inhibits the reaction [cadmium chloride results in decreased expression of CYP11A1 protein],,,PMID:31014900,https://www.ncbi.nlm.nih.gov/pubmed/31014900,31014900,,
373,1438270,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Cyanidin-3-O-beta-glucopyranoside results in decreased activity of CYP1A1 protein|[cyanidin-3-O-beta-glucopyranoside results in increased activity of AHR protein] which results in increased expression of CYP1A1 mrna|cyanidin-3-O-beta-glucopyranoside results in increased expression of CYP1A1 mRNA,,,PMID:23735880,https://www.ncbi.nlm.nih.gov/pubmed/23735880,23735880,,
374,1438271,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10090,Mus musculus (house mouse),Cyanidin-3-O-beta-glucopyranoside inhibits the reaction [cadmium chloride results in increased secretion of FSHB protein],,,PMID:31014900,https://www.ncbi.nlm.nih.gov/pubmed/31014900,31014900,,
375,1438272,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,2492,FSHR,https://ctdbase.org/detail.go?type=gene&acc=2492,,,2492.0,FSHR,10090,Mus musculus (house mouse),Cyanidin-3-O-beta-glucopyranoside inhibits the reaction [cadmium chloride results in decreased expression of FSHR mrna],,,PMID:31014900,https://www.ncbi.nlm.nih.gov/pubmed/31014900,31014900,,
376,1438273,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,2534,FYN,https://ctdbase.org/detail.go?type=gene&acc=2534,,,2534.0,FYN,10090,Mus musculus (house mouse),"Cyanidin-3-O-beta-glucopyranoside binds to FYN protein|[cyanidin-3-O-beta-glucopyranoside binds to FYN protein] which results in decreased activity of FYN protein|cyanidin-3-O-beta-glucopyranoside inhibits the reaction [7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased activity of FYN protein]",,,PMID:21501596,https://www.ncbi.nlm.nih.gov/pubmed/21501596,21501596,,
377,1438274,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606,Homo sapiens (human),[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of GCLC mRNA,,,PMID:27818126,https://www.ncbi.nlm.nih.gov/pubmed/27818126,27818126,,
378,1438275,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,9606,Homo sapiens (human),Cyanidin-3-O-beta-glucopyranoside promotes the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of GCLM mrna],,,PMID:27818126,https://www.ncbi.nlm.nih.gov/pubmed/27818126,27818126,,
379,1438276,441667,Comparative Toxicogenomics Database (CTD),Kuromanin,C462279,cyanidin-3-O-beta-glucopyranoside,https://ctdbase.org/detail.go?type=chem&acc=C462279,2796,GNRH1,https://ctdbase.org/detail.go?type=gene&acc=2796,,,2796.0,GNRH1,10090,Mus musculus (house mouse),Cyanidin-3-O-beta-glucopyranoside inhibits the reaction [cadmium chloride results in increased expression of GNRH1 mrna],,,PMID:31014900,https://www.ncbi.nlm.nih.gov/pubmed/31014900,31014900,,
380,1438990,442971,Comparative Toxicogenomics Database (CTD),alpha-Chaconine,C011860,alpha-chaconine,https://ctdbase.org/detail.go?type=chem&acc=C011860,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10090,Mus musculus (house mouse),"Alpha-chaconine inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased phosphorylation of MAPK8 protein]",,,PMID:25913072,https://www.ncbi.nlm.nih.gov/pubmed/25913072,25913072,,
381,1438991,442971,Comparative Toxicogenomics Database (CTD),alpha-Chaconine,C011860,alpha-chaconine,https://ctdbase.org/detail.go?type=chem&acc=C011860,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090,Mus musculus (house mouse),"Alpha-chaconine inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased phosphorylation of MAPK9 protein]",,,PMID:25913072,https://www.ncbi.nlm.nih.gov/pubmed/25913072,25913072,,
382,1438992,442971,Comparative Toxicogenomics Database (CTD),alpha-Chaconine,C011860,alpha-chaconine,https://ctdbase.org/detail.go?type=chem&acc=C011860,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),"Alpha-chaconine inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of NOS2 protein]|alpha-chaconine inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of NOS2 mrna]",,,PMID:25913072,https://www.ncbi.nlm.nih.gov/pubmed/25913072,25913072,,
383,1438993,442971,Comparative Toxicogenomics Database (CTD),alpha-Chaconine,C011860,alpha-chaconine,https://ctdbase.org/detail.go?type=chem&acc=C011860,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),"Alpha-chaconine inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of PTGS2 mrna]|alpha-chaconine inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of PTGS2 protein]",,,PMID:25913072,https://www.ncbi.nlm.nih.gov/pubmed/25913072,25913072,,
384,1438994,442971,Comparative Toxicogenomics Database (CTD),alpha-Chaconine,C011860,alpha-chaconine,https://ctdbase.org/detail.go?type=chem&acc=C011860,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Alpha-chaconine inhibits the reaction [lipopolysaccharides results in increased expression of TNF mrna]|alpha-chaconine inhibits the reaction [lipopolysaccharides results in increased expression of TNF protein],,,PMID:25913072,https://www.ncbi.nlm.nih.gov/pubmed/25913072,25913072,,
385,1439938,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55966,AJAP1,https://ctdbase.org/detail.go?type=gene&acc=55966,,,55966.0,AJAP1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of AJAP1 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
386,1440776,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),AKT1 protein modified form inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of CASP3 protein]]|akt1 protein modified form inhibits the reaction [wortmannin inhibits the reaction [[[sodium arsenite results in increased abundance of arsenic] which co-treated with benzo(a)pyrene] results in increased expression of MCL1 protein]]|[[sodium arsenite results in increased abundance of arsenic] which co-treated with benzo(a)pyrene] results in increased phosphorylation of AKT1 protein|akt1 protein modified form inhibits the reaction [wortmannin inhibits the reaction [[[ABT-737 co-treated with benzo(a)pyrene] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in decreased cleavage of PARP1 protein]]|wortmannin inhibits the reaction [[[sodium arsenite results in increased abundance of arsenic] which co-treated with benzo(a)pyrene] results in increased phosphorylation of AKT1 protein],,,PMID:32802178,https://www.ncbi.nlm.nih.gov/pubmed/32802178,32802178,,
387,1440777,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),SOCS3 protein inhibits the reaction [benzo(a)pyrene promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased phosphorylation of AKT1 protein]]|[[sodium arsenite results in increased abundance of arsenic] which co-treated with benzo(a)pyrene] results in increased phosphorylation of AKT1 protein|benzo(a)pyrene promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased phosphorylation of AKT1 protein],,,PMID:32062438,https://www.ncbi.nlm.nih.gov/pubmed/32062438,32062438,,
388,1440778,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),CXCL8 protein promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased phosphorylation of AKT1 protein]|genistein inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased phosphorylation of AKT1 protein]|lapatinib inhibits the reaction [CXCL8 protein promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased phosphorylation of AKT1 protein]]|reparixin inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased phosphorylation of AKT1 protein],,,PMID:33396024,https://www.ncbi.nlm.nih.gov/pubmed/33396024,33396024,,
389,1440886,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),[sodium arsenite co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in decreased phosphorylation of AKT1 protein,,,PMID:15028728,https://www.ncbi.nlm.nih.gov/pubmed/15028728,15028728,,
390,1440887,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),[sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] affects the expression of AKT1 mRNA,,,PMID:23192986,https://www.ncbi.nlm.nih.gov/pubmed/23192986,23192986,,
391,1440888,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),Sodium arsenite inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein],,,PMID:24535192,https://www.ncbi.nlm.nih.gov/pubmed/24535192,24535192,,
392,1440889,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of AKT1 mrna|sodium arsenite results in decreased expression of AKT1 protein,,,PMID:12760830,https://www.ncbi.nlm.nih.gov/pubmed/12760830,12760830,,
393,1441141,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84335,AKT1S1,https://ctdbase.org/detail.go?type=gene&acc=84335,,,84335.0,AKT1S1,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of AKT1S1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
394,1441142,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84335,AKT1S1,https://ctdbase.org/detail.go?type=gene&acc=84335,,,84335.0,AKT1S1,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of AKT1S1 mRNA,,,PMID:21297353,https://www.ncbi.nlm.nih.gov/pubmed/21297353,21297353,,
395,1441143,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,208,AKT2,https://ctdbase.org/detail.go?type=gene&acc=208,,,208.0,AKT2,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of AKT2 mRNA,,,PMID:19590694,https://www.ncbi.nlm.nih.gov/pubmed/19590694,19590694,,
396,1441144,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,208,AKT2,https://ctdbase.org/detail.go?type=gene&acc=208,,,208.0,AKT2,9606,Homo sapiens (human),Sodium arsenite results in decreased methylation of AKT2 gene,,,PMID:25199682,https://www.ncbi.nlm.nih.gov/pubmed/25199682,25199682,,
397,1441259,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,208,AKT2,https://ctdbase.org/detail.go?type=gene&acc=208,,,208.0,AKT2,10090,Mus musculus (house mouse),SEMA3A protein inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT2 protein]|sema4a protein promotes the reaction [sodium arsenite results in increased phosphorylation of AKT2 protein]|sodium arsenite results in increased phosphorylation of AKT2 protein,,,PMID:33290778,https://www.ncbi.nlm.nih.gov/pubmed/33290778,33290778,,
398,1441260,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,208,AKT2,https://ctdbase.org/detail.go?type=gene&acc=208,,,208.0,AKT2,10116,Rattus norvegicus (Norway rat),[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of AKT2 mrna|zingerone inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of AKT2 mrna],,,PMID:36822304,https://www.ncbi.nlm.nih.gov/pubmed/36822304,36822304,,
399,1441261,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10000,AKT3,https://ctdbase.org/detail.go?type=gene&acc=10000,,,10000.0,AKT3,9606,Homo sapiens (human),Sodium arsenite affects the methylation of AKT3 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
400,1441262,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10000,AKT3,https://ctdbase.org/detail.go?type=gene&acc=10000,,,10000.0,AKT3,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of AKT3 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
401,1441263,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10000,AKT3,https://ctdbase.org/detail.go?type=gene&acc=10000,,,10000.0,AKT3,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of and affects the splicing of AKT3 mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
402,1441399,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,10116,Rattus norvegicus (Norway rat),"[taurine co-treated with monoisoamyl-2,3-dimercaptosuccinate] inhibits the reaction [sodium arsenite results in decreased activity of ALAD protein]",,,PMID:19794907,https://www.ncbi.nlm.nih.gov/pubmed/19794907,19794907,,
403,1441400,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ALAS1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
404,1441401,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ALAS1 mRNA,,,PMID:25493608|PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25493608|https://www.ncbi.nlm.nih.gov/pubmed/25879800,25493608|25879800,,
405,1441522,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606,Homo sapiens (human),"Monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of ALB mrna]|sodium arsenite results in decreased expression of ALB mRNA",,,PMID:19615344,https://www.ncbi.nlm.nih.gov/pubmed/19615344,19615344,,
406,1441523,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606,Homo sapiens (human),Sodium arsenite affects the methylation of ALB gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
407,1441524,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ALB mRNA,,,PMID:28229933,https://www.ncbi.nlm.nih.gov/pubmed/28229933,28229933,,
408,1441525,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10090,Mus musculus (house mouse),[sodium arsenite co-treated with dietary fats] results in decreased expression of ALB protein,,,PMID:28593471,https://www.ncbi.nlm.nih.gov/pubmed/28593471,28593471,,
409,1441526,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ALB mRNA,,,PMID:26674514|PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/26674514|https://www.ncbi.nlm.nih.gov/pubmed/37682722,26674514|37682722,,
410,1441527,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10090,Mus musculus (house mouse),Sodium arsenite results in increased secretion of ALB protein,,,PMID:34272803,https://www.ncbi.nlm.nih.gov/pubmed/34272803,34272803,,
411,1441528,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10116,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [sodium arsenite results in decreased expression of ALB protein],,,PMID:18809455,https://www.ncbi.nlm.nih.gov/pubmed/18809455,18809455,,
412,1447391,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10565,ARFGEF1,https://ctdbase.org/detail.go?type=gene&acc=10565,,,10565.0,ARFGEF1,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ARFGEF1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
413,1447392,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10565,ARFGEF1,https://ctdbase.org/detail.go?type=gene&acc=10565,,,10565.0,ARFGEF1,10090,Mus musculus (house mouse),Sodium arsenite results in decreased methylation of ARFGEF1 gene,,,PMID:32068019,https://www.ncbi.nlm.nih.gov/pubmed/32068019,32068019,,
414,1551066,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,57497,LRFN2,https://ctdbase.org/detail.go?type=gene&acc=57497,,,57497.0,LRFN2,9606,Homo sapiens (human),Tretinoin results in decreased expression of LRFN2 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
415,1551067,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,78999,LRFN4,https://ctdbase.org/detail.go?type=gene&acc=78999,,,78999.0,LRFN4,9606,Homo sapiens (human),Tretinoin results in decreased expression of LRFN4 mRNA,,,PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/23830798,23830798,,
416,1551068,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,116844,LRG1,https://ctdbase.org/detail.go?type=gene&acc=116844,,,116844.0,LRG1,9606,Homo sapiens (human),Tretinoin results in increased expression of LRG1 mRNA,,,PMID:23830798|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23830798|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23830798|33167477,,
417,1530516,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,30816,ERVW-1,https://ctdbase.org/detail.go?type=gene&acc=30816,,,30816.0,ERVW-1,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of ERVW-1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
418,1530517,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,114799,ESCO1,https://ctdbase.org/detail.go?type=gene&acc=114799,,,114799.0,ESCO1,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of ESCO1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
419,1530628,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,135927,LLCFC1,https://ctdbase.org/detail.go?type=gene&acc=135927,,,135927.0,LLCFC1,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of LLCFC1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
420,1530629,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,84298,LLPH,https://ctdbase.org/detail.go?type=gene&acc=84298,,,84298.0,LLPH,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of LLPH mrna|[plant extracts co-treated with resveratrol] results in increased expression of LLPH mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
421,1530630,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,79748,LMAN1L,https://ctdbase.org/detail.go?type=gene&acc=79748,,,79748.0,LMAN1L,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of LMAN1L mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
422,1551069,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [aluminum chloride results in increased expression of MMP9 mrna]|resveratrol inhibits the reaction [aluminum chloride results in increased expression of MMP9 protein],,,PMID:35156769,https://www.ncbi.nlm.nih.gov/pubmed/35156769,35156769,,
423,1551070,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [calcium chloride results in increased activity of MMP9 protein],,,PMID:21530968,https://www.ncbi.nlm.nih.gov/pubmed/21530968,21530968,,
424,1517664,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,22864,R3HDM2,https://ctdbase.org/detail.go?type=gene&acc=22864,,,22864.0,R3HDM2,10116,Rattus norvegicus (Norway rat),Cocaine affects the expression of R3HDM2 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
425,1551162,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,10116,Rattus norvegicus (Norway rat),Thapsigargin results in increased expression of SQLE protein,,,PMID:35544339,https://www.ncbi.nlm.nih.gov/pubmed/35544339,35544339,,
426,1608297,470700,BindingDB,"4-({2-Ethyl-5-fluoro-9-methyl-10-oxo-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-13-yl}methoxy)-1-oxidopyridin-1-ium",2050,"2,8-disubstituted dipyridodiazepinone 33",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2050,66,"Gag-Pol polyprotein [600-1027,Y780C]/[600-1155,Y780C]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=66,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),300,PMID:9685236|DOI:10.1021/jm9707030,https://www.ncbi.nlm.nih.gov/pubmed/9685236|https://doi.org/10.1021/jm9707030,9685236,10.1021/jm9707030,
427,1608298,470701,BindingDB,"4-({5-Chloro-2-ethyl-9-methyl-10-oxo-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-13-yl}methoxy)-1-oxidopyridin-1-ium",2051,"2,8-disubstituted dipyridodiazepinone 34",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=2051,65,"Gag-Pol polyprotein [600-1027,R876K]/[600-1155]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=65,P03366,Gag-Pol polyprotein,,,11678,Human immunodeficiency virus type 1 BH10,,IC50 (nM),230,PMID:9685236|DOI:10.1021/jm9707030,https://www.ncbi.nlm.nih.gov/pubmed/9685236|https://doi.org/10.1021/jm9707030,9685236,10.1021/jm9707030,
428,1608186,3000322,Comparative Toxicogenomics Database (CTD),Scopolamine,D012601,Scopolamine,https://ctdbase.org/detail.go?type=chem&acc=D012601,2009,EML1,https://ctdbase.org/detail.go?type=gene&acc=2009,,,2009.0,EML1,10116,Rattus norvegicus (Norway rat),Scopolamine results in decreased expression of EML1 mRNA,,,PMID:17540011,https://www.ncbi.nlm.nih.gov/pubmed/17540011,17540011,,
429,2002132,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,26136,TES,https://ctdbase.org/detail.go?type=gene&acc=26136,,,26136.0,TES,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of TES mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
430,2012765,23665411,ChEMBL,Tolmetin Sodium,CHEMBL1200613,TOLMETIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200613/,CHEMBL2094253,Cyclooxygenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094253/,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606,Homo sapiens (human),Cyclooxygenase inhibitor,,,PMID:10377455|PMID:15458776,https://www.ncbi.nlm.nih.gov/pubmed/10377455|https://www.ncbi.nlm.nih.gov/pubmed/15458776,10377455|15458776,,
431,2012766,23665411,ChEMBL,Tolmetin Sodium,CHEMBL1200613,TOLMETIN SODIUM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200613/,CHEMBL2094253,Cyclooxygenase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094253/,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606,Homo sapiens (human),Cyclooxygenase inhibitor,,,PMID:10377455|PMID:15458776,https://www.ncbi.nlm.nih.gov/pubmed/10377455|https://www.ncbi.nlm.nih.gov/pubmed/15458776,10377455|15458776,,
432,2037224,25023761,BindingDB,"Imidazo[1,2-a]pyridine derivative, 14b",25057,"imidazo[1,2-a]pyridine derivative, 14b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25057,1622,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1622,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",5290.0,PIK3CA,9606,Homo sapiens (human),,IC50 (nM),20,PMID:17049248|DOI:10.1016/j.bmc.2006.09.047,https://www.ncbi.nlm.nih.gov/pubmed/17049248|https://doi.org/10.1016/j.bmc.2006.09.047,17049248,10.1016/j.bmc.2006.09.047,
433,2030314,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7544,ZFY,https://ctdbase.org/detail.go?type=gene&acc=7544,,,7544.0,ZFY,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZFY mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
434,2030315,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7546,ZIC2,https://ctdbase.org/detail.go?type=gene&acc=7546,,,7546.0,ZIC2,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZIC2 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
435,2030316,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,7568,ZNF20,https://ctdbase.org/detail.go?type=gene&acc=7568,,,7568.0,ZNF20,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of ZNF20 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
436,2037236,25138172,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 20",26425,"imidazo[1,2-c]pyrimidine-8-carboxamide, 20",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26425,763,Tyrosine-protein kinase SYK,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=763,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606,Homo sapiens (human),,IC50 (nM),>10000,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686,10.1016/j.bmc.2008.10.070,
437,2037237,25138172,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 20",26425,"imidazo[1,2-c]pyrimidine-8-carboxamide, 20",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26425,759,Tyrosine-protein kinase ZAP-70,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=759,P43403,Tyrosine-protein kinase ZAP-70,7535.0,ZAP70,9606,Homo sapiens (human),,IC50 (nM),3200,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686,10.1016/j.bmc.2008.10.070,
438,2056430,44388049,Therapeutic Target Database (TTD),"Des-AA1,2,4,5,6,12,13-[D-Trp8]SRIF",D0WG0O,"Des-AA1,2,4,5,6,12,13-[D-Trp8]SRIF",https://idrblab.net/ttd/data/drug/details/D0WG0O,T62974,Somatostatin receptor type 4 (SSTR4),https://idrblab.net/ttd/data/target/details/T62974,P31391,Somatostatin receptor type 4,6754.0,SSTR4,9606,Homo sapiens (human),Inhibitor,,,,,,,
439,2056431,44388049,Therapeutic Target Database (TTD),"Des-AA1,2,4,5,6,12,13-[D-Trp8]SRIF",D0WG0O,"Des-AA1,2,4,5,6,12,13-[D-Trp8]SRIF",https://idrblab.net/ttd/data/drug/details/D0WG0O,T53024,Somatostatin receptor type 2 (SSTR2),https://idrblab.net/ttd/data/target/details/T53024,P30874,Somatostatin receptor type 2,6752.0,SSTR2,9606,Homo sapiens (human),Inhibitor,,,,,,,
